Epithelial-Mesenchymal Transition, human (Scheel, 2011)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
ZEB1
|
ENSG00000148516.17 | ZEB1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
ZEB1 | hg19_v2_chr10_+_31608054_31608156 | -0.99 | 1.4e-06 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr8_+_95653427 | 30.91 |
ENST00000454170.2 |
ESRP1 |
epithelial splicing regulatory protein 1 |
chr8_+_95653373 | 29.30 |
ENST00000358397.5 |
ESRP1 |
epithelial splicing regulatory protein 1 |
chr8_+_95653302 | 29.16 |
ENST00000423620.2 ENST00000433389.2 |
ESRP1 |
epithelial splicing regulatory protein 1 |
chr14_-_61747949 | 28.39 |
ENST00000355702.2 |
TMEM30B |
transmembrane protein 30B |
chr19_+_35739597 | 27.35 |
ENST00000361790.3 |
LSR |
lipolysis stimulated lipoprotein receptor |
chr19_+_35739631 | 27.23 |
ENST00000602003.1 ENST00000360798.3 ENST00000354900.3 |
LSR |
lipolysis stimulated lipoprotein receptor |
chr19_+_35739782 | 26.94 |
ENST00000347609.4 |
LSR |
lipolysis stimulated lipoprotein receptor |
chr1_-_27286897 | 23.61 |
ENST00000320567.5 |
C1orf172 |
chromosome 1 open reading frame 172 |
chr6_-_136871957 | 23.43 |
ENST00000354570.3 |
MAP7 |
microtubule-associated protein 7 |
chr19_-_10697895 | 22.80 |
ENST00000591240.1 ENST00000589684.1 ENST00000591676.1 ENST00000250244.6 ENST00000590923.1 |
AP1M2 |
adaptor-related protein complex 1, mu 2 subunit |
chr19_+_38755203 | 22.55 |
ENST00000587090.1 ENST00000454580.3 |
SPINT2 |
serine peptidase inhibitor, Kunitz type, 2 |
chr19_+_38755042 | 22.46 |
ENST00000301244.7 |
SPINT2 |
serine peptidase inhibitor, Kunitz type, 2 |
chr19_+_35739897 | 21.39 |
ENST00000605618.1 ENST00000427250.1 ENST00000601623.1 |
LSR |
lipolysis stimulated lipoprotein receptor |
chr1_+_60280458 | 21.08 |
ENST00000455990.1 ENST00000371208.3 |
HOOK1 |
hook microtubule-tethering protein 1 |
chr19_+_35739280 | 20.85 |
ENST00000602122.1 |
LSR |
lipolysis stimulated lipoprotein receptor |
chr1_-_209979465 | 20.21 |
ENST00000542854.1 |
IRF6 |
interferon regulatory factor 6 |
chr16_+_68771128 | 20.17 |
ENST00000261769.5 ENST00000422392.2 |
CDH1 |
cadherin 1, type 1, E-cadherin (epithelial) |
chr16_+_68679193 | 19.47 |
ENST00000581171.1 |
CDH3 |
cadherin 3, type 1, P-cadherin (placental) |
chr1_+_62208091 | 19.38 |
ENST00000316485.6 ENST00000371158.2 |
INADL |
InaD-like (Drosophila) |
chr17_-_39942940 | 19.34 |
ENST00000310706.5 ENST00000393931.3 ENST00000424457.1 ENST00000591690.1 |
JUP |
junction plakoglobin |
chr15_+_41136586 | 18.93 |
ENST00000431806.1 |
SPINT1 |
serine peptidase inhibitor, Kunitz type 1 |
chr17_-_7165662 | 18.32 |
ENST00000571881.2 ENST00000360325.7 |
CLDN7 |
claudin 7 |
chr1_-_153588765 | 18.27 |
ENST00000368701.1 ENST00000344616.2 |
S100A14 |
S100 calcium binding protein A14 |
chr1_-_153588334 | 18.17 |
ENST00000476873.1 |
S100A14 |
S100 calcium binding protein A14 |
chr16_+_68678739 | 17.84 |
ENST00000264012.4 |
CDH3 |
cadherin 3, type 1, P-cadherin (placental) |
chr1_+_183155373 | 17.07 |
ENST00000493293.1 ENST00000264144.4 |
LAMC2 |
laminin, gamma 2 |
chr19_+_6464243 | 16.97 |
ENST00000600229.1 ENST00000356762.3 |
CRB3 |
crumbs homolog 3 (Drosophila) |
chr19_+_35606692 | 16.92 |
ENST00000406242.3 ENST00000454903.2 |
FXYD3 |
FXYD domain containing ion transport regulator 3 |
chr13_-_20806440 | 16.58 |
ENST00000400066.3 ENST00000400065.3 ENST00000356192.6 |
GJB6 |
gap junction protein, beta 6, 30kDa |
chr19_-_36001113 | 16.49 |
ENST00000434389.1 |
DMKN |
dermokine |
chr1_-_209979375 | 16.40 |
ENST00000367021.3 |
IRF6 |
interferon regulatory factor 6 |
chr19_+_6464502 | 16.18 |
ENST00000308243.7 |
CRB3 |
crumbs homolog 3 (Drosophila) |
chr16_+_68678892 | 16.16 |
ENST00000429102.2 |
CDH3 |
cadherin 3, type 1, P-cadherin (placental) |
chr19_-_51504411 | 16.13 |
ENST00000593490.1 |
KLK8 |
kallikrein-related peptidase 8 |
chr8_+_102504651 | 15.94 |
ENST00000251808.3 ENST00000521085.1 |
GRHL2 |
grainyhead-like 2 (Drosophila) |
chr5_+_68788594 | 14.51 |
ENST00000396442.2 ENST00000380766.2 |
OCLN |
occludin |
chr22_+_45148432 | 14.35 |
ENST00000389774.2 ENST00000396119.2 ENST00000336963.4 ENST00000356099.6 ENST00000412433.1 |
ARHGAP8 |
Rho GTPase activating protein 8 |
chr14_-_61748550 | 14.31 |
ENST00000555868.1 |
TMEM30B |
transmembrane protein 30B |
chr8_+_120220561 | 14.30 |
ENST00000276681.6 |
MAL2 |
mal, T-cell differentiation protein 2 (gene/pseudogene) |
chr14_-_105635090 | 13.83 |
ENST00000331782.3 ENST00000347004.2 |
JAG2 |
jagged 2 |
chr19_-_36001286 | 13.53 |
ENST00000602679.1 ENST00000492341.2 ENST00000472252.2 ENST00000602781.1 ENST00000402589.2 ENST00000458071.1 ENST00000436012.1 ENST00000443640.1 ENST00000450261.1 ENST00000467637.1 ENST00000480502.1 ENST00000474928.1 ENST00000414866.2 ENST00000392206.2 ENST00000488892.1 |
DMKN |
dermokine |
chr8_-_127570603 | 13.05 |
ENST00000304916.3 |
FAM84B |
family with sequence similarity 84, member B |
chr7_+_18535786 | 13.05 |
ENST00000406072.1 |
HDAC9 |
histone deacetylase 9 |
chr7_-_98030360 | 13.00 |
ENST00000005260.8 |
BAIAP2L1 |
BAI1-associated protein 2-like 1 |
chr1_-_201368653 | 12.61 |
ENST00000367313.3 |
LAD1 |
ladinin 1 |
chr1_-_201368707 | 12.54 |
ENST00000391967.2 |
LAD1 |
ladinin 1 |
chr19_-_6767431 | 12.38 |
ENST00000437152.3 ENST00000597687.1 |
SH2D3A |
SH2 domain containing 3A |
chr1_-_153363452 | 12.14 |
ENST00000368732.1 ENST00000368733.3 |
S100A8 |
S100 calcium binding protein A8 |
chr19_-_6767516 | 11.87 |
ENST00000245908.6 |
SH2D3A |
SH2 domain containing 3A |
chr7_-_22396533 | 11.67 |
ENST00000344041.6 |
RAPGEF5 |
Rap guanine nucleotide exchange factor (GEF) 5 |
chr1_+_44401479 | 11.65 |
ENST00000438616.3 |
ARTN |
artemin |
chr11_+_32851487 | 11.59 |
ENST00000257836.3 |
PRRG4 |
proline rich Gla (G-carboxyglutamic acid) 4 (transmembrane) |
chr4_-_74486217 | 11.53 |
ENST00000335049.5 ENST00000307439.5 |
RASSF6 |
Ras association (RalGDS/AF-6) domain family member 6 |
chr11_+_394196 | 11.41 |
ENST00000331563.2 ENST00000531857.1 |
PKP3 |
plakophilin 3 |
chr17_-_31204124 | 11.36 |
ENST00000579584.1 ENST00000318217.5 ENST00000583621.1 |
MYO1D |
myosin ID |
chr19_-_51522955 | 11.23 |
ENST00000358789.3 |
KLK10 |
kallikrein-related peptidase 10 |
chr2_+_120770686 | 11.09 |
ENST00000331393.4 ENST00000443124.1 |
EPB41L5 |
erythrocyte membrane protein band 4.1 like 5 |
chr11_-_118134997 | 11.02 |
ENST00000278937.2 |
MPZL2 |
myelin protein zero-like 2 |
chr19_+_35607166 | 11.01 |
ENST00000604255.1 ENST00000346446.5 ENST00000344013.6 ENST00000603449.1 ENST00000406988.1 ENST00000605550.1 ENST00000604804.1 ENST00000605552.1 |
FXYD3 |
FXYD domain containing ion transport regulator 3 |
chr16_-_68269971 | 10.74 |
ENST00000565858.1 |
ESRP2 |
epithelial splicing regulatory protein 2 |
chr19_+_45843994 | 10.70 |
ENST00000391946.2 |
KLC3 |
kinesin light chain 3 |
chr22_+_40390930 | 10.50 |
ENST00000333407.6 |
FAM83F |
family with sequence similarity 83, member F |
chr1_+_95285896 | 10.45 |
ENST00000446120.2 ENST00000271227.6 ENST00000527077.1 ENST00000529450.1 |
SLC44A3 |
solute carrier family 44, member 3 |
chr17_+_73521763 | 10.09 |
ENST00000167462.5 ENST00000375227.4 ENST00000392550.3 ENST00000578363.1 ENST00000579392.1 |
LLGL2 |
lethal giant larvae homolog 2 (Drosophila) |
chr9_-_126030817 | 10.02 |
ENST00000348403.5 ENST00000447404.2 ENST00000360998.3 |
STRBP |
spermatid perinuclear RNA binding protein |
chr2_+_47596287 | 9.96 |
ENST00000263735.4 |
EPCAM |
epithelial cell adhesion molecule |
chr1_-_159915386 | 9.86 |
ENST00000361509.3 ENST00000368094.1 |
IGSF9 |
immunoglobulin superfamily, member 9 |
chr6_+_7541808 | 9.74 |
ENST00000379802.3 |
DSP |
desmoplakin |
chr19_+_35606777 | 9.72 |
ENST00000604404.1 ENST00000435734.2 ENST00000603181.1 |
FXYD3 |
FXYD domain containing ion transport regulator 3 |
chr1_-_160990886 | 9.64 |
ENST00000537746.1 |
F11R |
F11 receptor |
chr16_+_57653989 | 9.57 |
ENST00000567835.1 ENST00000569372.1 ENST00000563548.1 ENST00000562003.1 |
GPR56 |
G protein-coupled receptor 56 |
chr16_+_57653854 | 9.57 |
ENST00000568908.1 ENST00000568909.1 ENST00000566778.1 ENST00000561988.1 |
GPR56 |
G protein-coupled receptor 56 |
chr1_-_55266926 | 9.56 |
ENST00000371276.4 |
TTC22 |
tetratricopeptide repeat domain 22 |
chr6_+_7541845 | 9.55 |
ENST00000418664.2 |
DSP |
desmoplakin |
chr19_-_51523275 | 9.48 |
ENST00000309958.3 |
KLK10 |
kallikrein-related peptidase 10 |
chr3_-_69435224 | 9.43 |
ENST00000398540.3 |
FRMD4B |
FERM domain containing 4B |
chr1_-_207206092 | 9.39 |
ENST00000359470.5 ENST00000461135.2 |
C1orf116 |
chromosome 1 open reading frame 116 |
chr11_+_18287721 | 9.35 |
ENST00000356524.4 |
SAA1 |
serum amyloid A1 |
chr11_+_18287801 | 9.33 |
ENST00000532858.1 ENST00000405158.2 |
SAA1 |
serum amyloid A1 |
chr1_+_3370990 | 9.32 |
ENST00000378378.4 |
ARHGEF16 |
Rho guanine nucleotide exchange factor (GEF) 16 |
chr2_-_165477971 | 9.27 |
ENST00000446413.2 |
GRB14 |
growth factor receptor-bound protein 14 |
chr12_-_53298841 | 9.22 |
ENST00000293308.6 |
KRT8 |
keratin 8 |
chr6_+_54711533 | 9.14 |
ENST00000306858.7 |
FAM83B |
family with sequence similarity 83, member B |
chr1_+_35220613 | 9.09 |
ENST00000338513.1 |
GJB5 |
gap junction protein, beta 5, 31.1kDa |
chr1_+_1981890 | 9.01 |
ENST00000378567.3 ENST00000468310.1 |
PRKCZ |
protein kinase C, zeta |
chr8_+_82644669 | 8.94 |
ENST00000297265.4 |
CHMP4C |
charged multivesicular body protein 4C |
chr1_+_44399466 | 8.90 |
ENST00000498139.2 ENST00000491846.1 |
ARTN |
artemin |
chr11_-_17035943 | 8.89 |
ENST00000355661.3 ENST00000532079.1 ENST00000448080.2 ENST00000531066.1 |
PLEKHA7 |
pleckstrin homology domain containing, family A member 7 |
chr12_+_56473628 | 8.89 |
ENST00000549282.1 ENST00000549061.1 ENST00000267101.3 |
ERBB3 |
v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 3 |
chr11_-_118135160 | 8.86 |
ENST00000438295.2 |
MPZL2 |
myelin protein zero-like 2 |
chr1_+_95582881 | 8.85 |
ENST00000370203.4 ENST00000456991.1 |
TMEM56 |
transmembrane protein 56 |
chr1_+_152956549 | 8.85 |
ENST00000307122.2 |
SPRR1A |
small proline-rich protein 1A |
chr17_-_39674668 | 8.82 |
ENST00000393981.3 |
KRT15 |
keratin 15 |
chr6_+_150464155 | 8.74 |
ENST00000361131.4 |
PPP1R14C |
protein phosphatase 1, regulatory (inhibitor) subunit 14C |
chr17_-_38657849 | 8.66 |
ENST00000254051.6 |
TNS4 |
tensin 4 |
chr17_+_9548845 | 8.66 |
ENST00000570475.1 ENST00000285199.7 |
USP43 |
ubiquitin specific peptidase 43 |
chr19_+_45844018 | 8.58 |
ENST00000585434.1 |
KLC3 |
kinesin light chain 3 |
chr18_-_74844713 | 8.53 |
ENST00000397860.3 |
MBP |
myelin basic protein |
chr19_+_39279838 | 8.52 |
ENST00000314980.4 |
LGALS7B |
lectin, galactoside-binding, soluble, 7B |
chr12_-_6484715 | 8.49 |
ENST00000228916.2 |
SCNN1A |
sodium channel, non-voltage-gated 1 alpha subunit |
chr6_+_27215494 | 8.44 |
ENST00000230582.3 |
PRSS16 |
protease, serine, 16 (thymus) |
chr2_-_216878305 | 8.40 |
ENST00000263268.6 |
MREG |
melanoregulin |
chr6_+_27215471 | 8.40 |
ENST00000421826.2 |
PRSS16 |
protease, serine, 16 (thymus) |
chr15_+_41136216 | 8.35 |
ENST00000562057.1 ENST00000344051.4 |
SPINT1 |
serine peptidase inhibitor, Kunitz type 1 |
chr19_+_45844032 | 8.18 |
ENST00000589837.1 |
KLC3 |
kinesin light chain 3 |
chr14_+_75745477 | 8.18 |
ENST00000303562.4 ENST00000554617.1 ENST00000554212.1 ENST00000535987.1 ENST00000555242.1 |
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
chr19_-_54676846 | 8.10 |
ENST00000301187.4 |
TMC4 |
transmembrane channel-like 4 |
chr19_+_55587266 | 8.01 |
ENST00000201647.6 ENST00000540810.1 |
EPS8L1 |
EPS8-like 1 |
chr5_-_60140089 | 7.99 |
ENST00000507047.1 ENST00000438340.1 ENST00000425382.1 ENST00000508821.1 |
ELOVL7 |
ELOVL fatty acid elongase 7 |
chr16_-_4987065 | 7.99 |
ENST00000590782.2 ENST00000345988.2 |
PPL |
periplakin |
chr1_+_44398943 | 7.99 |
ENST00000372359.5 ENST00000414809.3 |
ARTN |
artemin |
chr6_+_41604747 | 7.98 |
ENST00000419164.1 ENST00000373051.2 |
MDFI |
MyoD family inhibitor |
chr10_+_71389983 | 7.97 |
ENST00000373279.4 |
C10orf35 |
chromosome 10 open reading frame 35 |
chr4_+_85504075 | 7.90 |
ENST00000295887.5 |
CDS1 |
CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1 |
chr11_-_18270182 | 7.68 |
ENST00000528349.1 ENST00000526900.1 ENST00000529528.1 ENST00000414546.2 ENST00000256733.4 |
SAA2 |
serum amyloid A2 |
chr1_+_156030937 | 7.63 |
ENST00000361084.5 |
RAB25 |
RAB25, member RAS oncogene family |
chr11_+_69924397 | 7.51 |
ENST00000355303.5 |
ANO1 |
anoctamin 1, calcium activated chloride channel |
chr17_-_76124711 | 7.43 |
ENST00000306591.7 ENST00000590602.1 |
TMC6 |
transmembrane channel-like 6 |
chr12_+_20848282 | 7.40 |
ENST00000545604.1 |
SLCO1C1 |
solute carrier organic anion transporter family, member 1C1 |
chr4_+_155665123 | 7.37 |
ENST00000336356.3 |
LRAT |
lecithin retinol acyltransferase (phosphatidylcholine--retinol O-acyltransferase) |
chr12_+_20848377 | 7.27 |
ENST00000540354.1 ENST00000266509.2 ENST00000381552.1 |
SLCO1C1 |
solute carrier organic anion transporter family, member 1C1 |
chr22_+_45098067 | 7.18 |
ENST00000336985.6 ENST00000403696.1 ENST00000457960.1 ENST00000361473.5 |
PRR5 PRR5-ARHGAP8 |
proline rich 5 (renal) PRR5-ARHGAP8 readthrough |
chr16_+_71660079 | 7.13 |
ENST00000565261.1 ENST00000268485.3 ENST00000299952.4 |
MARVELD3 |
MARVEL domain containing 3 |
chr19_-_54676884 | 7.11 |
ENST00000376591.4 |
TMC4 |
transmembrane channel-like 4 |
chr5_-_60140009 | 7.10 |
ENST00000505959.1 |
ELOVL7 |
ELOVL fatty acid elongase 7 |
chr2_+_223289208 | 7.09 |
ENST00000321276.7 |
SGPP2 |
sphingosine-1-phosphate phosphatase 2 |
chr6_+_30850697 | 7.02 |
ENST00000509639.1 ENST00000412274.2 ENST00000507901.1 ENST00000507046.1 ENST00000437124.2 ENST00000454612.2 ENST00000396342.2 |
DDR1 |
discoidin domain receptor tyrosine kinase 1 |
chr5_+_68711209 | 6.99 |
ENST00000512803.1 |
MARVELD2 |
MARVEL domain containing 2 |
chr1_+_234349957 | 6.94 |
ENST00000366617.3 |
SLC35F3 |
solute carrier family 35, member F3 |
chr17_-_76124812 | 6.92 |
ENST00000592063.1 ENST00000589271.1 ENST00000322933.4 ENST00000589553.1 |
TMC6 |
transmembrane channel-like 6 |
chr19_+_45281118 | 6.82 |
ENST00000270279.3 ENST00000341505.4 |
CBLC |
Cbl proto-oncogene C, E3 ubiquitin protein ligase |
chr7_+_26331541 | 6.78 |
ENST00000416246.1 ENST00000338523.4 ENST00000412416.1 |
SNX10 |
sorting nexin 10 |
chr8_+_32406179 | 6.78 |
ENST00000405005.3 |
NRG1 |
neuregulin 1 |
chr18_+_34124507 | 6.74 |
ENST00000591635.1 |
FHOD3 |
formin homology 2 domain containing 3 |
chr6_+_36097992 | 6.64 |
ENST00000211287.4 |
MAPK13 |
mitogen-activated protein kinase 13 |
chr5_+_68710906 | 6.63 |
ENST00000325631.5 ENST00000454295.2 |
MARVELD2 |
MARVEL domain containing 2 |
chr17_-_74497432 | 6.60 |
ENST00000590288.1 ENST00000313080.4 ENST00000592123.1 ENST00000591255.1 ENST00000585989.1 ENST00000591697.1 ENST00000389760.4 |
RHBDF2 |
rhomboid 5 homolog 2 (Drosophila) |
chr4_-_74486109 | 6.58 |
ENST00000395777.2 |
RASSF6 |
Ras association (RalGDS/AF-6) domain family member 6 |
chr7_-_22233442 | 6.54 |
ENST00000401957.2 |
RAPGEF5 |
Rap guanine nucleotide exchange factor (GEF) 5 |
chr11_+_45944190 | 6.54 |
ENST00000401752.1 ENST00000389968.3 ENST00000325468.5 ENST00000536139.1 |
GYLTL1B |
glycosyltransferase-like 1B |
chr1_-_242612779 | 6.52 |
ENST00000427495.1 |
PLD5 |
phospholipase D family, member 5 |
chr8_-_144815966 | 6.51 |
ENST00000388913.3 |
FAM83H |
family with sequence similarity 83, member H |
chr18_-_28681950 | 6.47 |
ENST00000251081.6 |
DSC2 |
desmocollin 2 |
chr14_+_21510385 | 6.43 |
ENST00000298690.4 |
RNASE7 |
ribonuclease, RNase A family, 7 |
chr9_+_93564039 | 6.41 |
ENST00000375754.4 ENST00000375751.4 |
SYK |
spleen tyrosine kinase |
chr19_-_51456198 | 6.38 |
ENST00000594846.1 |
KLK5 |
kallikrein-related peptidase 5 |
chr7_-_143105941 | 6.38 |
ENST00000275815.3 |
EPHA1 |
EPH receptor A1 |
chr8_+_86376081 | 6.34 |
ENST00000285379.5 |
CA2 |
carbonic anhydrase II |
chr12_-_52911718 | 6.31 |
ENST00000548409.1 |
KRT5 |
keratin 5 |
chr9_+_93564191 | 6.31 |
ENST00000375747.1 |
SYK |
spleen tyrosine kinase |
chr3_-_69435428 | 6.25 |
ENST00000542259.1 |
FRMD4B |
FERM domain containing 4B |
chr9_-_23821273 | 6.25 |
ENST00000380110.4 |
ELAVL2 |
ELAV like neuron-specific RNA binding protein 2 |
chr12_+_56732658 | 6.25 |
ENST00000228534.4 |
IL23A |
interleukin 23, alpha subunit p19 |
chr5_+_167718604 | 6.25 |
ENST00000265293.4 |
WWC1 |
WW and C2 domain containing 1 |
chr12_-_48298785 | 6.24 |
ENST00000550325.1 ENST00000546653.1 ENST00000549336.1 ENST00000535672.1 ENST00000229022.3 ENST00000548664.1 |
VDR |
vitamin D (1,25- dihydroxyvitamin D3) receptor |
chr18_-_28682374 | 6.22 |
ENST00000280904.6 |
DSC2 |
desmocollin 2 |
chr11_-_112034803 | 6.19 |
ENST00000528832.1 |
IL18 |
interleukin 18 (interferon-gamma-inducing factor) |
chr1_+_26503894 | 6.17 |
ENST00000361530.6 ENST00000374253.5 |
CNKSR1 |
connector enhancer of kinase suppressor of Ras 1 |
chr17_-_3599492 | 6.14 |
ENST00000435558.1 ENST00000345901.3 |
P2RX5 |
purinergic receptor P2X, ligand-gated ion channel, 5 |
chr1_+_152957707 | 6.10 |
ENST00000368762.1 |
SPRR1A |
small proline-rich protein 1A |
chr9_-_139948487 | 6.10 |
ENST00000355097.2 |
ENTPD2 |
ectonucleoside triphosphate diphosphohydrolase 2 |
chr2_+_17721230 | 6.05 |
ENST00000457525.1 |
VSNL1 |
visinin-like 1 |
chr3_-_48471454 | 6.01 |
ENST00000296440.6 ENST00000448774.2 |
PLXNB1 |
plexin B1 |
chr11_-_11643540 | 6.00 |
ENST00000227756.4 |
GALNT18 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 18 |
chr20_+_49348081 | 5.96 |
ENST00000371610.2 |
PARD6B |
par-6 family cell polarity regulator beta |
chr18_-_47721447 | 5.94 |
ENST00000285039.7 |
MYO5B |
myosin VB |
chr8_+_31497271 | 5.90 |
ENST00000520407.1 |
NRG1 |
neuregulin 1 |
chr5_-_1882858 | 5.89 |
ENST00000511126.1 ENST00000231357.2 |
IRX4 |
iroquois homeobox 4 |
chr2_+_17721920 | 5.88 |
ENST00000295156.4 |
VSNL1 |
visinin-like 1 |
chr1_-_85514120 | 5.85 |
ENST00000370589.2 ENST00000341115.4 ENST00000370587.1 |
MCOLN3 |
mucolipin 3 |
chr4_+_75311019 | 5.82 |
ENST00000502307.1 |
AREG |
amphiregulin |
chr11_+_65554493 | 5.77 |
ENST00000335987.3 |
OVOL1 |
ovo-like zinc finger 1 |
chr22_+_29469012 | 5.76 |
ENST00000400335.4 ENST00000400338.2 |
KREMEN1 |
kringle containing transmembrane protein 1 |
chr11_+_59522900 | 5.75 |
ENST00000529177.1 |
STX3 |
syntaxin 3 |
chr4_+_75310851 | 5.75 |
ENST00000395748.3 ENST00000264487.2 |
AREG |
amphiregulin |
chr21_-_42219065 | 5.71 |
ENST00000400454.1 |
DSCAM |
Down syndrome cell adhesion molecule |
chr17_+_73717551 | 5.69 |
ENST00000450894.3 |
ITGB4 |
integrin, beta 4 |
chr17_-_39684550 | 5.67 |
ENST00000455635.1 ENST00000361566.3 |
KRT19 |
keratin 19 |
chr11_-_112034780 | 5.67 |
ENST00000524595.1 |
IL18 |
interleukin 18 (interferon-gamma-inducing factor) |
chr1_+_95286151 | 5.65 |
ENST00000467909.1 ENST00000422520.2 ENST00000532427.1 |
SLC44A3 |
solute carrier family 44, member 3 |
chr16_+_71660052 | 5.65 |
ENST00000567566.1 |
MARVELD3 |
MARVEL domain containing 3 |
chr11_-_112034831 | 5.65 |
ENST00000280357.7 |
IL18 |
interleukin 18 (interferon-gamma-inducing factor) |
chr20_-_18038521 | 5.63 |
ENST00000278780.6 |
OVOL2 |
ovo-like zinc finger 2 |
chr11_+_59522532 | 5.61 |
ENST00000337979.4 ENST00000535361.1 |
STX3 |
syntaxin 3 |
chr9_+_35673853 | 5.58 |
ENST00000378357.4 |
CA9 |
carbonic anhydrase IX |
chr1_+_109792641 | 5.56 |
ENST00000271332.3 |
CELSR2 |
cadherin, EGF LAG seven-pass G-type receptor 2 |
chrX_+_105969893 | 5.54 |
ENST00000255499.2 |
RNF128 |
ring finger protein 128, E3 ubiquitin protein ligase |
chr2_-_70780770 | 5.53 |
ENST00000444975.1 ENST00000445399.1 ENST00000418333.2 |
TGFA |
transforming growth factor, alpha |
chr17_+_73717407 | 5.52 |
ENST00000579662.1 |
ITGB4 |
integrin, beta 4 |
chr19_-_19739007 | 5.47 |
ENST00000586703.1 ENST00000591042.1 ENST00000407877.3 |
LPAR2 |
lysophosphatidic acid receptor 2 |
chr4_+_75480629 | 5.40 |
ENST00000380846.3 |
AREGB |
amphiregulin B |
chr17_-_56494713 | 5.38 |
ENST00000407977.2 |
RNF43 |
ring finger protein 43 |
chr17_-_56494882 | 5.36 |
ENST00000584437.1 |
RNF43 |
ring finger protein 43 |
chr17_-_56494908 | 5.34 |
ENST00000577716.1 |
RNF43 |
ring finger protein 43 |
chr9_-_131940526 | 5.34 |
ENST00000372491.2 |
IER5L |
immediate early response 5-like |
chr15_+_89182178 | 5.31 |
ENST00000559876.1 |
ISG20 |
interferon stimulated exonuclease gene 20kDa |
chr15_+_74833518 | 5.31 |
ENST00000346246.5 |
ARID3B |
AT rich interactive domain 3B (BRIGHT-like) |
chr7_+_16793160 | 5.28 |
ENST00000262067.4 |
TSPAN13 |
tetraspanin 13 |
chr2_-_70780572 | 5.27 |
ENST00000450929.1 |
TGFA |
transforming growth factor, alpha |
chr1_+_32042105 | 5.25 |
ENST00000457433.2 ENST00000441210.2 |
TINAGL1 |
tubulointerstitial nephritis antigen-like 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
24.8 | 123.8 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
17.8 | 53.5 | GO:0032773 | regulation of monophenol monooxygenase activity(GO:0032771) positive regulation of monophenol monooxygenase activity(GO:0032773) negative regulation of catagen(GO:0051796) regulation of hair cycle by canonical Wnt signaling pathway(GO:0060901) positive regulation of melanosome transport(GO:1902910) |
12.2 | 60.9 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
6.1 | 55.0 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
5.7 | 28.5 | GO:0097021 | Peyer's patch morphogenesis(GO:0061146) lymphocyte migration into lymphoid organs(GO:0097021) |
5.7 | 11.4 | GO:0002159 | desmosome assembly(GO:0002159) |
5.0 | 30.0 | GO:1903575 | cornified envelope assembly(GO:1903575) |
4.4 | 17.5 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
4.1 | 8.2 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
3.8 | 11.3 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
3.2 | 16.1 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
3.2 | 12.7 | GO:0045401 | response to molecule of fungal origin(GO:0002238) positive regulation of interleukin-3 production(GO:0032752) interleukin-3 biosynthetic process(GO:0042223) regulation of interleukin-3 biosynthetic process(GO:0045399) positive regulation of interleukin-3 biosynthetic process(GO:0045401) cellular response to molecule of fungal origin(GO:0071226) |
3.2 | 19.0 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
3.2 | 3.2 | GO:2000981 | negative regulation of mechanoreceptor differentiation(GO:0045632) negative regulation of inner ear receptor cell differentiation(GO:2000981) |
3.0 | 8.9 | GO:0032499 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) detection of peptidoglycan(GO:0032499) |
3.0 | 14.8 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
2.9 | 20.6 | GO:0021840 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
2.8 | 38.6 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
2.6 | 2.6 | GO:0072554 | blood vessel lumenization(GO:0072554) |
2.4 | 16.7 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
2.3 | 16.4 | GO:0098967 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
2.3 | 2.3 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
2.3 | 7.0 | GO:1901994 | meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) negative regulation of meiotic cell cycle phase transition(GO:1901994) |
2.2 | 6.7 | GO:1902565 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
2.2 | 17.7 | GO:0001661 | conditioned taste aversion(GO:0001661) |
2.2 | 13.1 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
2.2 | 30.1 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
2.1 | 6.3 | GO:0042938 | dipeptide transport(GO:0042938) |
2.1 | 16.7 | GO:0031642 | negative regulation of myelination(GO:0031642) |
2.1 | 6.2 | GO:0051142 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
2.1 | 6.2 | GO:0060057 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
2.1 | 14.5 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
2.1 | 8.2 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
2.0 | 15.7 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
1.9 | 5.7 | GO:0048627 | myoblast development(GO:0048627) |
1.9 | 55.3 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
1.9 | 5.7 | GO:0060086 | circadian temperature homeostasis(GO:0060086) |
1.8 | 16.2 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
1.8 | 5.4 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
1.8 | 8.9 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
1.7 | 3.5 | GO:0002302 | CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
1.7 | 5.1 | GO:0051066 | dihydrobiopterin metabolic process(GO:0051066) |
1.7 | 5.1 | GO:0043163 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
1.7 | 10.1 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
1.7 | 1.7 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
1.7 | 5.0 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
1.6 | 3.2 | GO:0002586 | regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
1.6 | 14.4 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
1.6 | 3.2 | GO:0048817 | negative regulation of hair follicle maturation(GO:0048817) |
1.6 | 7.8 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
1.6 | 23.4 | GO:0051639 | actin filament network formation(GO:0051639) |
1.5 | 18.5 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
1.5 | 6.2 | GO:0072660 | maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
1.5 | 4.6 | GO:0045014 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
1.5 | 6.1 | GO:2000569 | T-helper 2 cell activation(GO:0035712) regulation of T-helper 2 cell activation(GO:2000569) positive regulation of T-helper 2 cell activation(GO:2000570) |
1.5 | 39.6 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
1.4 | 11.6 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
1.4 | 8.6 | GO:0002225 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
1.4 | 7.0 | GO:0015888 | thiamine transport(GO:0015888) |
1.4 | 4.1 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
1.3 | 6.5 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
1.3 | 3.8 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
1.3 | 5.1 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
1.2 | 17.3 | GO:0070327 | thyroid hormone transport(GO:0070327) |
1.2 | 6.1 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
1.2 | 2.5 | GO:0031133 | regulation of axon diameter(GO:0031133) |
1.2 | 3.6 | GO:0002522 | leukocyte migration involved in immune response(GO:0002522) |
1.2 | 7.1 | GO:0003160 | endocardium morphogenesis(GO:0003160) endocardium formation(GO:0060214) |
1.2 | 16.4 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
1.2 | 4.7 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
1.2 | 102.5 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
1.1 | 3.4 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
1.1 | 3.4 | GO:0045659 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
1.1 | 3.4 | GO:0061216 | apoptotic process involved in endocardial cushion morphogenesis(GO:0003277) tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) intermediate mesoderm morphogenesis(GO:0048390) intermediate mesoderm formation(GO:0048391) intermediate mesodermal cell differentiation(GO:0048392) regulation of cardiac muscle fiber development(GO:0055018) positive regulation of cardiac muscle fiber development(GO:0055020) bud dilation involved in lung branching(GO:0060503) BMP signaling pathway involved in ureter morphogenesis(GO:0061149) renal system segmentation(GO:0061150) BMP signaling pathway involved in renal system segmentation(GO:0061151) pulmonary artery endothelial tube morphogenesis(GO:0061155) regulation of transcription from RNA polymerase II promoter involved in mesonephros development(GO:0061216) BMP signaling pathway involved in nephric duct formation(GO:0071893) negative regulation of branch elongation involved in ureteric bud branching(GO:0072096) negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway(GO:0072097) anterior/posterior pattern specification involved in ureteric bud development(GO:0072099) specification of ureteric bud anterior/posterior symmetry(GO:0072100) specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway(GO:0072101) ureter epithelial cell differentiation(GO:0072192) negative regulation of mesenchymal cell proliferation involved in ureter development(GO:0072200) regulation of cell proliferation involved in outflow tract morphogenesis(GO:1901963) positive regulation of cell proliferation involved in outflow tract morphogenesis(GO:1901964) cardiac jelly development(GO:1905072) regulation of metanephric S-shaped body morphogenesis(GO:2000004) negative regulation of metanephric S-shaped body morphogenesis(GO:2000005) regulation of metanephric comma-shaped body morphogenesis(GO:2000006) negative regulation of metanephric comma-shaped body morphogenesis(GO:2000007) |
1.1 | 4.5 | GO:0050712 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
1.1 | 3.4 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) |
1.1 | 5.6 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) |
1.1 | 3.3 | GO:1902568 | regulation of eosinophil degranulation(GO:0043309) positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
1.1 | 3.3 | GO:0055099 | detection of endogenous stimulus(GO:0009726) response to high density lipoprotein particle(GO:0055099) |
1.1 | 5.4 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
1.1 | 3.2 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
1.1 | 4.2 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
1.1 | 31.7 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
1.0 | 3.1 | GO:0042351 | 'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
1.0 | 16.6 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
1.0 | 11.3 | GO:0032119 | sequestering of zinc ion(GO:0032119) |
1.0 | 4.1 | GO:0061588 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylserine scrambling(GO:0061589) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
1.0 | 1.0 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
1.0 | 1.0 | GO:1903923 | protein processing in phagocytic vesicle(GO:1900756) regulation of protein processing in phagocytic vesicle(GO:1903921) positive regulation of protein processing in phagocytic vesicle(GO:1903923) |
1.0 | 2.9 | GO:1904897 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
1.0 | 11.4 | GO:1904936 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.9 | 3.8 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.9 | 4.7 | GO:1903412 | response to bile acid(GO:1903412) |
0.9 | 5.6 | GO:0009137 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.9 | 3.7 | GO:0071469 | detection of mechanical stimulus involved in sensory perception of touch(GO:0050976) cellular response to alkaline pH(GO:0071469) |
0.9 | 3.6 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
0.9 | 3.6 | GO:0007509 | mesoderm migration involved in gastrulation(GO:0007509) |
0.9 | 3.5 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.9 | 25.5 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.9 | 4.3 | GO:0015688 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
0.9 | 2.6 | GO:0018153 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
0.9 | 13.8 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.9 | 1.7 | GO:0072179 | nephric duct formation(GO:0072179) |
0.9 | 2.6 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.8 | 3.3 | GO:0035627 | ceramide transport(GO:0035627) |
0.8 | 3.3 | GO:1904823 | pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
0.8 | 0.8 | GO:0042640 | anagen(GO:0042640) |
0.8 | 8.2 | GO:0032782 | bile acid secretion(GO:0032782) |
0.8 | 8.9 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.8 | 2.4 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.8 | 7.2 | GO:0015705 | iodide transport(GO:0015705) |
0.8 | 4.0 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.8 | 2.4 | GO:0060738 | epithelial-mesenchymal signaling involved in prostate gland development(GO:0060738) |
0.8 | 7.0 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.8 | 3.9 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.8 | 1.5 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.8 | 2.3 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.8 | 12.9 | GO:0015871 | choline transport(GO:0015871) |
0.8 | 2.3 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
0.8 | 3.8 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.7 | 3.0 | GO:0034343 | type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) |
0.7 | 6.6 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.7 | 5.8 | GO:0032439 | endosome localization(GO:0032439) |
0.7 | 5.1 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.7 | 3.6 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
0.7 | 4.2 | GO:0030035 | microspike assembly(GO:0030035) |
0.7 | 3.5 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.7 | 12.5 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.7 | 4.9 | GO:0051673 | membrane disruption in other organism(GO:0051673) |
0.7 | 4.9 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.7 | 5.5 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
0.7 | 15.2 | GO:0003334 | keratinocyte development(GO:0003334) |
0.7 | 13.0 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.7 | 2.0 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.7 | 11.5 | GO:0061436 | regulation of water loss via skin(GO:0033561) establishment of skin barrier(GO:0061436) |
0.7 | 0.7 | GO:0001172 | transcription, RNA-templated(GO:0001172) |
0.7 | 2.0 | GO:1903028 | positive regulation of opsonization(GO:1903028) |
0.7 | 6.6 | GO:0032264 | IMP salvage(GO:0032264) |
0.7 | 15.1 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.6 | 13.6 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.6 | 3.2 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.6 | 20.4 | GO:0050716 | positive regulation of interleukin-1 secretion(GO:0050716) |
0.6 | 3.8 | GO:0060005 | vestibular reflex(GO:0060005) |
0.6 | 3.2 | GO:0048749 | compound eye development(GO:0048749) |
0.6 | 10.7 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.6 | 3.7 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.6 | 7.5 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.6 | 9.8 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.6 | 3.1 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.6 | 7.3 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.6 | 4.2 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.6 | 0.6 | GO:1904862 | inhibitory synapse assembly(GO:1904862) |
0.6 | 2.4 | GO:0007402 | ganglion mother cell fate determination(GO:0007402) |
0.6 | 1.8 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.6 | 2.4 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.6 | 1.8 | GO:2000329 | peptidyl-lysine oxidation(GO:0018057) negative regulation of T-helper 17 cell lineage commitment(GO:2000329) |
0.6 | 1.8 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.6 | 1.8 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
0.6 | 26.0 | GO:0098927 | vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.6 | 89.1 | GO:0008543 | fibroblast growth factor receptor signaling pathway(GO:0008543) |
0.6 | 2.8 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.6 | 1.7 | GO:0002325 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.6 | 1.1 | GO:0021558 | trochlear nerve development(GO:0021558) |
0.6 | 3.9 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
0.6 | 8.3 | GO:0051665 | membrane raft localization(GO:0051665) |
0.6 | 2.2 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
0.5 | 5.8 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.5 | 1.6 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
0.5 | 4.2 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.5 | 5.7 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
0.5 | 7.2 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.5 | 2.6 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
0.5 | 1.5 | GO:0097069 | cellular response to thyroxine stimulus(GO:0097069) cellular response to L-phenylalanine derivative(GO:1904387) |
0.5 | 2.5 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) |
0.5 | 1.0 | GO:0036466 | synaptic vesicle recycling via endosome(GO:0036466) |
0.5 | 2.5 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.5 | 0.5 | GO:1903826 | arginine transmembrane transport(GO:1903826) |
0.5 | 1.0 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.5 | 1.5 | GO:0033600 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.5 | 1.4 | GO:0035962 | response to interleukin-13(GO:0035962) |
0.5 | 1.0 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.5 | 6.7 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.5 | 1.9 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.5 | 1.4 | GO:0042214 | terpene metabolic process(GO:0042214) |
0.5 | 0.5 | GO:0055069 | zinc ion homeostasis(GO:0055069) |
0.5 | 1.4 | GO:1902473 | regulation of protein localization to synapse(GO:1902473) positive regulation of protein localization to synapse(GO:1902474) |
0.5 | 2.3 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.5 | 1.9 | GO:0002316 | follicular B cell differentiation(GO:0002316) |
0.5 | 2.3 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.5 | 6.3 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.4 | 30.8 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.4 | 1.3 | GO:0090156 | cellular sphingolipid homeostasis(GO:0090156) |
0.4 | 1.7 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.4 | 0.4 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
0.4 | 3.9 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.4 | 2.6 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.4 | 1.3 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
0.4 | 0.4 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
0.4 | 2.1 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
0.4 | 3.4 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.4 | 3.8 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
0.4 | 44.7 | GO:0070268 | cornification(GO:0070268) |
0.4 | 2.1 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
0.4 | 1.2 | GO:0006425 | glutaminyl-tRNA aminoacylation(GO:0006425) |
0.4 | 0.8 | GO:0009644 | response to high light intensity(GO:0009644) |
0.4 | 4.6 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.4 | 1.2 | GO:0006258 | UDP-glucose catabolic process(GO:0006258) |
0.4 | 2.1 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
0.4 | 1.6 | GO:0015783 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
0.4 | 1.6 | GO:1904245 | regulation of polynucleotide adenylyltransferase activity(GO:1904245) |
0.4 | 2.8 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.4 | 2.8 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.4 | 1.2 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.4 | 2.8 | GO:0051126 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
0.4 | 0.4 | GO:0002085 | inhibition of neuroepithelial cell differentiation(GO:0002085) |
0.4 | 12.2 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.4 | 0.8 | GO:0097695 | establishment of RNA localization to telomere(GO:0097694) establishment of macromolecular complex localization to telomere(GO:0097695) |
0.4 | 4.3 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.4 | 4.3 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.4 | 1.5 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.4 | 1.5 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
0.4 | 1.1 | GO:0072156 | distal tubule morphogenesis(GO:0072156) |
0.4 | 2.2 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.4 | 1.1 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
0.4 | 0.4 | GO:1903903 | establishment of T cell polarity(GO:0001768) regulation of establishment of T cell polarity(GO:1903903) |
0.4 | 3.2 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.4 | 0.7 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.4 | 1.1 | GO:0007518 | myoblast fate determination(GO:0007518) |
0.4 | 1.1 | GO:0048075 | positive regulation of eye pigmentation(GO:0048075) |
0.4 | 1.4 | GO:0010820 | regulation of T cell chemotaxis(GO:0010819) positive regulation of T cell chemotaxis(GO:0010820) |
0.4 | 1.4 | GO:0021633 | optic nerve structural organization(GO:0021633) |
0.3 | 1.0 | GO:2000863 | positive regulation of estrogen secretion(GO:2000863) positive regulation of estradiol secretion(GO:2000866) |
0.3 | 0.7 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.3 | 1.4 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.3 | 11.6 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
0.3 | 1.4 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.3 | 2.4 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.3 | 1.7 | GO:0097475 | motor neuron migration(GO:0097475) |
0.3 | 1.0 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.3 | 3.9 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.3 | 22.9 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.3 | 2.9 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.3 | 1.3 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
0.3 | 1.3 | GO:0090107 | aminophospholipid transport(GO:0015917) regulation of high-density lipoprotein particle assembly(GO:0090107) |
0.3 | 1.0 | GO:0042727 | flavin-containing compound biosynthetic process(GO:0042727) |
0.3 | 2.2 | GO:1900625 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.3 | 1.2 | GO:2000568 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
0.3 | 13.9 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
0.3 | 6.4 | GO:0009886 | post-embryonic morphogenesis(GO:0009886) |
0.3 | 0.3 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.3 | 0.9 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.3 | 1.5 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.3 | 3.6 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.3 | 3.0 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
0.3 | 1.8 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.3 | 1.2 | GO:0033504 | floor plate development(GO:0033504) |
0.3 | 2.6 | GO:0009629 | response to gravity(GO:0009629) |
0.3 | 0.9 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.3 | 0.3 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.3 | 0.9 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
0.3 | 7.8 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.3 | 13.5 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.3 | 2.6 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.3 | 1.7 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.3 | 0.9 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.3 | 0.3 | GO:0060056 | mammary gland involution(GO:0060056) |
0.3 | 1.4 | GO:0036005 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
0.3 | 6.3 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.3 | 2.6 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.3 | 1.1 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.3 | 0.8 | GO:1902723 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
0.3 | 1.1 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.3 | 0.8 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
0.3 | 3.6 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.3 | 0.3 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.3 | 1.1 | GO:0006288 | base-excision repair, DNA ligation(GO:0006288) |
0.3 | 1.1 | GO:0021622 | optic cup structural organization(GO:0003409) oculomotor nerve development(GO:0021557) oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
0.3 | 0.8 | GO:1902075 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) cellular response to salt(GO:1902075) response to sodium arsenite(GO:1903935) cellular response to sodium arsenite(GO:1903936) positive regulation of miRNA metabolic process(GO:2000630) |
0.3 | 0.8 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.3 | 7.1 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.3 | 3.2 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.3 | 3.2 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.3 | 4.2 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.3 | 4.9 | GO:0034063 | stress granule assembly(GO:0034063) |
0.3 | 1.0 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.3 | 3.6 | GO:0015884 | folic acid transport(GO:0015884) |
0.3 | 2.0 | GO:1900107 | regulation of nodal signaling pathway(GO:1900107) |
0.3 | 0.8 | GO:0006106 | fumarate metabolic process(GO:0006106) aspartate biosynthetic process(GO:0006532) aspartate catabolic process(GO:0006533) |
0.3 | 0.5 | GO:1901631 | positive regulation of presynaptic membrane organization(GO:1901631) positive regulation of synaptic vesicle clustering(GO:2000809) |
0.3 | 1.3 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.3 | 1.3 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.3 | 0.5 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.2 | 1.7 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.2 | 0.2 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.2 | 1.0 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.2 | 2.0 | GO:0006477 | protein sulfation(GO:0006477) |
0.2 | 3.7 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.2 | 0.7 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.2 | 0.7 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
0.2 | 1.2 | GO:0010761 | fibroblast migration(GO:0010761) |
0.2 | 3.2 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.2 | 0.7 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
0.2 | 2.0 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.2 | 0.5 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.2 | 4.6 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
0.2 | 1.2 | GO:0015862 | uridine transport(GO:0015862) |
0.2 | 2.2 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.2 | 0.5 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.2 | 0.7 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.2 | 0.2 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.2 | 1.2 | GO:0007000 | nucleolus organization(GO:0007000) |
0.2 | 1.8 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.2 | 0.7 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
0.2 | 0.2 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
0.2 | 2.7 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.2 | 2.0 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.2 | 1.8 | GO:0097240 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.2 | 0.9 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.2 | 2.0 | GO:0006489 | dolichyl diphosphate biosynthetic process(GO:0006489) dolichyl diphosphate metabolic process(GO:0046465) |
0.2 | 0.9 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.2 | 1.1 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.2 | 0.4 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.2 | 3.3 | GO:0000050 | urea cycle(GO:0000050) |
0.2 | 0.7 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
0.2 | 1.1 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.2 | 2.4 | GO:0014029 | neural crest formation(GO:0014029) |
0.2 | 0.6 | GO:0044209 | AMP salvage(GO:0044209) |
0.2 | 1.3 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
0.2 | 1.5 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.2 | 1.3 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
0.2 | 2.5 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.2 | 0.6 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
0.2 | 0.6 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
0.2 | 2.7 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.2 | 2.9 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.2 | 2.1 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.2 | 0.6 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
0.2 | 6.4 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.2 | 3.4 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.2 | 32.1 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.2 | 0.8 | GO:1902460 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
0.2 | 0.4 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.2 | 0.8 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.2 | 2.0 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.2 | 1.2 | GO:0052551 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
0.2 | 0.6 | GO:0019242 | methylglyoxal biosynthetic process(GO:0019242) |
0.2 | 0.6 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.2 | 1.4 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
0.2 | 0.8 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) protein K33-linked deubiquitination(GO:1990168) |
0.2 | 2.5 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.2 | 1.9 | GO:0060071 | Wnt signaling pathway, planar cell polarity pathway(GO:0060071) |
0.2 | 6.7 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
0.2 | 1.7 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.2 | 0.9 | GO:1904764 | late endosomal microautophagy(GO:0061738) negative regulation of fibril organization(GO:1902904) chaperone-mediated autophagy translocation complex disassembly(GO:1904764) |
0.2 | 1.3 | GO:0030220 | platelet formation(GO:0030220) |
0.2 | 0.4 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.2 | 18.4 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.2 | 1.5 | GO:2001212 | regulation of vasculogenesis(GO:2001212) |
0.2 | 7.0 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.2 | 0.9 | GO:0009624 | response to nematode(GO:0009624) |
0.2 | 0.9 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) |
0.2 | 1.1 | GO:0001878 | response to yeast(GO:0001878) |
0.2 | 0.6 | GO:1901876 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
0.2 | 1.8 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.2 | 0.7 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.2 | 2.7 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.2 | 0.7 | GO:0032484 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
0.2 | 0.5 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.2 | 1.1 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
0.2 | 0.2 | GO:0033092 | positive regulation of immature T cell proliferation(GO:0033091) positive regulation of immature T cell proliferation in thymus(GO:0033092) |
0.2 | 0.7 | GO:0002266 | follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
0.2 | 5.5 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.2 | 5.8 | GO:0032402 | melanosome transport(GO:0032402) |
0.2 | 0.9 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.2 | 0.5 | GO:0031938 | regulation of chromatin silencing at telomere(GO:0031938) |
0.2 | 0.2 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
0.2 | 1.2 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.2 | 0.5 | GO:0008050 | female courtship behavior(GO:0008050) |
0.2 | 8.4 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.2 | 0.7 | GO:0045844 | positive regulation of striated muscle tissue development(GO:0045844) positive regulation of muscle organ development(GO:0048636) positive regulation of muscle tissue development(GO:1901863) |
0.2 | 0.9 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.2 | 4.2 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.2 | 5.1 | GO:0032456 | endocytic recycling(GO:0032456) |
0.2 | 0.7 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
0.2 | 0.5 | GO:0050894 | determination of affect(GO:0050894) |
0.2 | 0.3 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
0.2 | 0.8 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.2 | 0.5 | GO:1901253 | negative regulation of intracellular transport of viral material(GO:1901253) |
0.2 | 0.3 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.2 | 2.6 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.2 | 2.0 | GO:0046033 | AMP metabolic process(GO:0046033) |
0.2 | 2.3 | GO:0036120 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.2 | 1.8 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
0.2 | 0.6 | GO:0072209 | metanephric mesangial cell differentiation(GO:0072209) metanephric glomerular mesangial cell differentiation(GO:0072254) metanephric glomerular mesangial cell development(GO:0072255) reversible differentiation(GO:0090677) cell dedifferentiation involved in phenotypic switching(GO:0090678) regulation of hyaluronan biosynthetic process(GO:1900125) positive regulation of hyaluronan biosynthetic process(GO:1900127) positive regulation of phenotypic switching(GO:1900241) regulation of vascular smooth muscle cell dedifferentiation(GO:1905174) positive regulation of vascular smooth muscle cell dedifferentiation(GO:1905176) vascular smooth muscle cell dedifferentiation(GO:1990936) |
0.2 | 1.8 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.2 | 1.7 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.2 | 4.7 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.2 | 0.9 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.2 | 0.6 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.2 | 0.3 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.2 | 1.2 | GO:0090220 | chromosome localization to nuclear envelope involved in homologous chromosome segregation(GO:0090220) |
0.2 | 2.3 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
0.1 | 0.6 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.1 | 3.1 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.1 | 1.5 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) protein localization to photoreceptor outer segment(GO:1903546) |
0.1 | 0.9 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.1 | 0.3 | GO:0051608 | histamine transport(GO:0051608) |
0.1 | 1.6 | GO:1904152 | regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
0.1 | 0.3 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
0.1 | 0.4 | GO:0070105 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) regulation of interleukin-6-mediated signaling pathway(GO:0070103) positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
0.1 | 0.3 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.1 | 8.3 | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
0.1 | 2.3 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.1 | 0.6 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.1 | 0.1 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.1 | 0.3 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.1 | 0.1 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 0.7 | GO:0099551 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
0.1 | 1.1 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.1 | 0.6 | GO:0003011 | involuntary skeletal muscle contraction(GO:0003011) |
0.1 | 0.4 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
0.1 | 0.5 | GO:0043335 | protein unfolding(GO:0043335) |
0.1 | 1.6 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.1 | 6.8 | GO:0007340 | acrosome reaction(GO:0007340) |
0.1 | 0.3 | GO:0044205 | 'de novo' UMP biosynthetic process(GO:0044205) |
0.1 | 0.9 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.1 | 0.4 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.1 | 0.3 | GO:0002901 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.1 | 0.7 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.1 | 1.2 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.1 | 1.9 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
0.1 | 1.0 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.1 | 0.2 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.1 | 0.5 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
0.1 | 1.5 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
0.1 | 3.0 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.1 | 1.2 | GO:0001676 | long-chain fatty acid metabolic process(GO:0001676) |
0.1 | 1.1 | GO:1903297 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) |
0.1 | 1.2 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 0.4 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.1 | 0.5 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 2.6 | GO:0005980 | glycogen catabolic process(GO:0005980) |
0.1 | 0.5 | GO:0035900 | response to isolation stress(GO:0035900) |
0.1 | 0.4 | GO:0002818 | intracellular defense response(GO:0002818) |
0.1 | 0.5 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 1.8 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.1 | 0.5 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.1 | 0.6 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) determination of liver left/right asymmetry(GO:0071910) |
0.1 | 1.4 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.1 | 2.3 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.1 | 0.3 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.1 | 3.0 | GO:0072663 | protein targeting to peroxisome(GO:0006625) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.1 | 2.8 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.1 | 0.8 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.1 | 0.4 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.1 | 0.9 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.1 | 1.0 | GO:0098700 | neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.1 | 1.1 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.1 | 3.0 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 1.2 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
0.1 | 0.9 | GO:0042048 | olfactory behavior(GO:0042048) |
0.1 | 4.7 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.1 | 1.4 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.1 | 0.8 | GO:0002931 | response to ischemia(GO:0002931) |
0.1 | 0.4 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.1 | 0.5 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.1 | 0.4 | GO:0045176 | apical protein localization(GO:0045176) |
0.1 | 3.0 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.1 | 0.9 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.1 | 1.3 | GO:0051601 | exocyst localization(GO:0051601) |
0.1 | 2.0 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.1 | 2.8 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.1 | 0.9 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.1 | 1.4 | GO:0060749 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.1 | 0.8 | GO:0061450 | trophoblast cell migration(GO:0061450) regulation of trophoblast cell migration(GO:1901163) negative regulation of trophoblast cell migration(GO:1901164) |
0.1 | 0.3 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.1 | 0.6 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) positive regulation of blood vessel remodeling(GO:2000504) |
0.1 | 4.1 | GO:0019985 | translesion synthesis(GO:0019985) |
0.1 | 0.5 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.1 | 0.3 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 1.6 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.1 | 0.5 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.1 | 4.2 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
0.1 | 0.6 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.1 | 0.3 | GO:0097104 | postsynaptic membrane assembly(GO:0097104) |
0.1 | 0.6 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) |
0.1 | 0.1 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
0.1 | 0.9 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.1 | 0.8 | GO:0035634 | response to stilbenoid(GO:0035634) |
0.1 | 0.7 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.1 | 1.0 | GO:1901880 | negative regulation of protein depolymerization(GO:1901880) |
0.1 | 0.4 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.9 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.1 | 0.9 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.1 | 4.3 | GO:1902475 | L-alpha-amino acid transmembrane transport(GO:1902475) |
0.1 | 0.5 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
0.1 | 2.0 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.1 | 0.3 | GO:0061760 | antifungal innate immune response(GO:0061760) |
0.1 | 1.0 | GO:0060512 | prostate gland morphogenesis(GO:0060512) |
0.1 | 0.4 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
0.1 | 0.4 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.1 | 0.4 | GO:2000490 | negative regulation of hepatic stellate cell activation(GO:2000490) |
0.1 | 2.5 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 0.7 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.1 | 0.1 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
0.1 | 1.1 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.1 | 1.6 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.1 | 0.5 | GO:0071241 | cellular response to inorganic substance(GO:0071241) |
0.1 | 0.3 | GO:0016240 | autophagosome docking(GO:0016240) |
0.1 | 2.9 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
0.1 | 0.2 | GO:0003149 | membranous septum morphogenesis(GO:0003149) |
0.1 | 0.9 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.1 | 0.3 | GO:0021722 | pons maturation(GO:0021586) superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
0.1 | 0.2 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) |
0.1 | 1.0 | GO:0030307 | positive regulation of cell growth(GO:0030307) |
0.1 | 0.4 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.1 | 0.5 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.1 | 0.3 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
0.1 | 0.7 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.1 | 2.5 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.1 | 1.1 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 1.2 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 1.9 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 0.4 | GO:0034308 | primary alcohol metabolic process(GO:0034308) |
0.1 | 0.4 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.1 | 1.5 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.1 | 0.7 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.1 | 1.0 | GO:0052697 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.1 | 1.8 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.1 | 1.6 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.1 | 1.1 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.1 | 0.4 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.1 | 0.3 | GO:0090649 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
0.1 | 0.5 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.1 | 0.5 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
0.1 | 1.3 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.1 | 1.5 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
0.1 | 0.2 | GO:0016071 | mRNA metabolic process(GO:0016071) |
0.1 | 0.8 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
0.1 | 0.1 | GO:0003253 | cardiac neural crest cell migration involved in outflow tract morphogenesis(GO:0003253) |
0.1 | 0.1 | GO:1902595 | regulation of DNA replication origin binding(GO:1902595) |
0.1 | 0.2 | GO:0002881 | microglial cell activation involved in immune response(GO:0002282) negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
0.1 | 0.3 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
0.1 | 0.5 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.1 | 1.2 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
0.1 | 0.5 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.1 | 0.3 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.1 | 1.0 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.1 | 0.1 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.1 | 0.7 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.1 | 0.7 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
0.1 | 0.2 | GO:1904970 | brush border assembly(GO:1904970) |
0.1 | 0.2 | GO:0097398 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
0.1 | 0.5 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
0.1 | 0.8 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.1 | 0.6 | GO:0051852 | disruption by host of symbiont cells(GO:0051852) |
0.1 | 0.6 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
0.1 | 0.3 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
0.1 | 0.3 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
0.1 | 0.8 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 1.3 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.1 | 1.1 | GO:0007625 | grooming behavior(GO:0007625) |
0.1 | 0.9 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 0.3 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 0.4 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.1 | 0.3 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
0.1 | 0.7 | GO:0015780 | nucleotide-sugar transport(GO:0015780) |
0.1 | 1.6 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 4.5 | GO:0050729 | positive regulation of inflammatory response(GO:0050729) |
0.1 | 1.3 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 1.6 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.1 | 0.3 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.1 | 0.7 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.1 | 7.5 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.1 | 0.7 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.1 | 1.9 | GO:0050918 | positive chemotaxis(GO:0050918) |
0.1 | 0.2 | GO:0043383 | negative T cell selection(GO:0043383) |
0.1 | 0.3 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 0.2 | GO:0030860 | neuroblast division in subventricular zone(GO:0021849) regulation of polarized epithelial cell differentiation(GO:0030860) |
0.1 | 0.9 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.1 | 0.4 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.1 | 1.5 | GO:0033006 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
0.1 | 0.4 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.1 | 0.1 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.1 | 0.3 | GO:0070829 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
0.1 | 0.9 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.1 | 0.6 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.1 | 1.9 | GO:0030201 | heparan sulfate proteoglycan metabolic process(GO:0030201) |
0.1 | 0.9 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.3 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.1 | 3.8 | GO:0006400 | tRNA modification(GO:0006400) |
0.1 | 0.2 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.1 | 0.4 | GO:0036486 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
0.1 | 0.7 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.1 | 0.2 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
0.1 | 1.0 | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
0.1 | 0.5 | GO:0071872 | cellular response to epinephrine stimulus(GO:0071872) |
0.1 | 1.2 | GO:1901663 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.1 | 0.4 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.1 | 0.4 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
0.1 | 0.5 | GO:0002517 | T cell tolerance induction(GO:0002517) |
0.1 | 1.2 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.1 | 0.9 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 0.3 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.1 | 0.9 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.1 | 0.2 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.1 | 0.6 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.0 | 0.2 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.0 | 0.3 | GO:0048730 | epidermis morphogenesis(GO:0048730) |
0.0 | 0.1 | GO:0032679 | TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) |
0.0 | 2.3 | GO:0030279 | negative regulation of ossification(GO:0030279) |
0.0 | 0.0 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
0.0 | 0.3 | GO:0030242 | pexophagy(GO:0030242) |
0.0 | 0.7 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.0 | 1.0 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.0 | 0.2 | GO:0034086 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.0 | 2.9 | GO:0030183 | B cell differentiation(GO:0030183) |
0.0 | 1.3 | GO:0033574 | response to testosterone(GO:0033574) |
0.0 | 0.6 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.0 | 0.3 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.0 | 0.4 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.0 | 0.2 | GO:0048263 | determination of dorsal identity(GO:0048263) |
0.0 | 0.7 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.0 | 2.2 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.4 | GO:0042749 | regulation of circadian sleep/wake cycle(GO:0042749) regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
0.0 | 0.5 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 1.1 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
0.0 | 0.9 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.0 | 0.3 | GO:0072678 | T cell migration(GO:0072678) |
0.0 | 0.7 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
0.0 | 1.2 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.0 | 1.1 | GO:0008347 | glial cell migration(GO:0008347) |
0.0 | 0.6 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.0 | 1.5 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.0 | 0.1 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.0 | 1.3 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.0 | 0.9 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.0 | 0.0 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.0 | 0.2 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
0.0 | 0.4 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.0 | 0.2 | GO:0030575 | nuclear body organization(GO:0030575) |
0.0 | 0.8 | GO:0007099 | centriole replication(GO:0007099) |
0.0 | 0.3 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.0 | 0.3 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
0.0 | 4.7 | GO:0007163 | establishment or maintenance of cell polarity(GO:0007163) |
0.0 | 0.2 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.0 | 3.2 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.0 | 0.7 | GO:0045124 | regulation of bone resorption(GO:0045124) |
0.0 | 0.2 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.0 | 1.4 | GO:0042255 | ribosome assembly(GO:0042255) |
0.0 | 0.7 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.0 | 0.1 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.0 | 0.6 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.0 | 25.9 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
0.0 | 0.2 | GO:0021854 | hypothalamus development(GO:0021854) |
0.0 | 0.2 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.0 | 0.2 | GO:0001975 | response to amphetamine(GO:0001975) |
0.0 | 0.3 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.0 | 0.1 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.0 | 0.6 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.0 | 0.4 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.0 | 0.5 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.0 | 0.0 | GO:0070445 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
0.0 | 0.1 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.0 | 0.2 | GO:2000269 | regulation of fibroblast apoptotic process(GO:2000269) |
0.0 | 0.3 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.0 | 0.3 | GO:0036315 | cellular response to sterol(GO:0036315) |
0.0 | 0.7 | GO:0007141 | male meiosis I(GO:0007141) |
0.0 | 1.2 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.0 | 0.3 | GO:0045066 | regulatory T cell differentiation(GO:0045066) regulation of regulatory T cell differentiation(GO:0045589) |
0.0 | 0.3 | GO:0006069 | ethanol oxidation(GO:0006069) |
0.0 | 0.2 | GO:0072310 | glomerular epithelial cell development(GO:0072310) |
0.0 | 0.4 | GO:0097369 | sodium ion import(GO:0097369) |
0.0 | 0.2 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.0 | 0.1 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.0 | 0.2 | GO:0009249 | protein lipoylation(GO:0009249) |
0.0 | 1.0 | GO:1901216 | positive regulation of neuron death(GO:1901216) |
0.0 | 0.4 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.0 | 0.1 | GO:1901798 | positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.0 | 0.3 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.0 | 0.4 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.0 | 0.1 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.0 | 0.5 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.0 | 3.4 | GO:0030449 | regulation of complement activation(GO:0030449) |
0.0 | 3.2 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.0 | 0.5 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.0 | 0.3 | GO:0046916 | cellular transition metal ion homeostasis(GO:0046916) |
0.0 | 0.7 | GO:0006825 | copper ion transport(GO:0006825) |
0.0 | 0.1 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
0.0 | 0.2 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.0 | 0.1 | GO:0046951 | cellular ketone body metabolic process(GO:0046950) ketone body biosynthetic process(GO:0046951) |
0.0 | 0.2 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.0 | 0.6 | GO:0072384 | organelle transport along microtubule(GO:0072384) |
0.0 | 0.6 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.0 | 1.0 | GO:0010955 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.0 | 0.3 | GO:0098743 | cell aggregation(GO:0098743) |
0.0 | 0.1 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.0 | 0.9 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.3 | GO:0035082 | axoneme assembly(GO:0035082) |
0.0 | 0.5 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.0 | 0.1 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.0 | 0.2 | GO:0015886 | heme transport(GO:0015886) |
0.0 | 0.4 | GO:1904816 | regulation of protein localization to chromosome, telomeric region(GO:1904814) positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.0 | 0.1 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.0 | 1.2 | GO:0021987 | cerebral cortex development(GO:0021987) |
0.0 | 1.1 | GO:0045740 | positive regulation of DNA replication(GO:0045740) |
0.0 | 0.2 | GO:1901314 | negative regulation of histone ubiquitination(GO:0033183) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) |
0.0 | 0.2 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.0 | 0.3 | GO:0006086 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) |
0.0 | 0.3 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.0 | 0.1 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.0 | 0.2 | GO:0042355 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.0 | 2.3 | GO:0016197 | endosomal transport(GO:0016197) |
0.0 | 0.2 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.7 | GO:0046849 | bone remodeling(GO:0046849) |
0.0 | 0.1 | GO:0032309 | icosanoid secretion(GO:0032309) |
0.0 | 1.0 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 0.1 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.0 | 0.3 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.0 | 0.1 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.8 | GO:0008033 | tRNA processing(GO:0008033) |
0.0 | 0.6 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.3 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.0 | 0.1 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
0.0 | 0.2 | GO:0032098 | regulation of appetite(GO:0032098) |
0.0 | 1.3 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.1 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) regulation of microtubule depolymerization(GO:0031114) |
0.0 | 0.2 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.0 | 0.1 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.0 | 0.1 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.0 | 0.1 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.0 | 0.2 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.0 | 0.1 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.0 | 0.1 | GO:0008228 | opsonization(GO:0008228) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
14.8 | 133.6 | GO:0061689 | tricellular tight junction(GO:0061689) |
5.4 | 16.3 | GO:0005607 | laminin-2 complex(GO:0005607) |
4.2 | 12.7 | GO:0034676 | integrin alpha6-beta4 complex(GO:0034676) |
4.1 | 16.4 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
3.5 | 24.8 | GO:0070695 | FHF complex(GO:0070695) |
2.9 | 35.3 | GO:0016342 | catenin complex(GO:0016342) |
2.4 | 12.1 | GO:1990357 | terminal web(GO:1990357) |
2.2 | 17.5 | GO:0035976 | AP1 complex(GO:0035976) |
2.2 | 21.6 | GO:0005916 | fascia adherens(GO:0005916) |
1.9 | 60.4 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
1.8 | 29.5 | GO:0035253 | ciliary rootlet(GO:0035253) |
1.8 | 3.6 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
1.7 | 11.6 | GO:0019815 | B cell receptor complex(GO:0019815) |
1.6 | 4.8 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
1.5 | 10.5 | GO:0097209 | epidermal lamellar body(GO:0097209) |
1.4 | 15.6 | GO:0045179 | apical cortex(GO:0045179) |
1.3 | 44.4 | GO:0030057 | desmosome(GO:0030057) |
1.3 | 14.1 | GO:0005915 | zonula adherens(GO:0005915) |
1.1 | 9.9 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
1.1 | 24.2 | GO:0005922 | connexon complex(GO:0005922) |
0.9 | 9.4 | GO:0033269 | internode region of axon(GO:0033269) |
0.9 | 7.4 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.9 | 2.7 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
0.9 | 15.2 | GO:0030056 | hemidesmosome(GO:0030056) |
0.9 | 6.2 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.8 | 3.8 | GO:0034678 | integrin alpha8-beta1 complex(GO:0034678) |
0.7 | 7.4 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.7 | 4.2 | GO:0044194 | cytolytic granule(GO:0044194) |
0.7 | 2.1 | GO:0032002 | interleukin-28 receptor complex(GO:0032002) |
0.7 | 6.1 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.7 | 10.9 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.7 | 66.7 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.6 | 18.6 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
0.6 | 25.9 | GO:0030673 | axolemma(GO:0030673) |
0.6 | 2.4 | GO:0032437 | cuticular plate(GO:0032437) |
0.6 | 2.4 | GO:1990031 | pinceau fiber(GO:1990031) |
0.6 | 10.0 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.6 | 10.2 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.5 | 18.6 | GO:0001533 | cornified envelope(GO:0001533) |
0.5 | 74.2 | GO:0070160 | occluding junction(GO:0070160) |
0.5 | 1.5 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
0.5 | 13.5 | GO:0034706 | sodium channel complex(GO:0034706) |
0.5 | 12.2 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.5 | 1.8 | GO:0070985 | TFIIK complex(GO:0070985) |
0.4 | 3.9 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.4 | 1.3 | GO:0030849 | Y chromosome(GO:0000806) autosome(GO:0030849) |
0.4 | 2.1 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.4 | 20.3 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.4 | 3.2 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.4 | 0.4 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.4 | 7.6 | GO:0001891 | phagocytic cup(GO:0001891) |
0.4 | 9.3 | GO:0031143 | pseudopodium(GO:0031143) |
0.4 | 2.5 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.3 | 8.4 | GO:0005861 | troponin complex(GO:0005861) |
0.3 | 3.0 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.3 | 1.3 | GO:0035339 | SPOTS complex(GO:0035339) |
0.3 | 1.7 | GO:0098536 | deuterosome(GO:0098536) |
0.3 | 1.6 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.3 | 16.4 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.3 | 0.9 | GO:0044609 | DBIRD complex(GO:0044609) |
0.3 | 36.7 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.3 | 3.3 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.3 | 3.5 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.3 | 6.5 | GO:0031932 | TORC2 complex(GO:0031932) |
0.3 | 0.3 | GO:0060171 | stereocilium membrane(GO:0060171) |
0.3 | 1.1 | GO:0031085 | BLOC-3 complex(GO:0031085) |
0.3 | 0.5 | GO:0005656 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
0.3 | 7.9 | GO:0016580 | Sin3 complex(GO:0016580) |
0.2 | 8.2 | GO:0005605 | basal lamina(GO:0005605) |
0.2 | 0.7 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
0.2 | 23.8 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.2 | 1.0 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.2 | 2.9 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.2 | 17.0 | GO:0045095 | keratin filament(GO:0045095) |
0.2 | 1.1 | GO:0016234 | inclusion body(GO:0016234) |
0.2 | 0.7 | GO:0031379 | RNA-directed RNA polymerase complex(GO:0031379) |
0.2 | 1.3 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.2 | 0.9 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.2 | 3.9 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.2 | 1.3 | GO:0071817 | MMXD complex(GO:0071817) |
0.2 | 1.5 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.2 | 1.1 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.2 | 0.8 | GO:1990742 | microvesicle(GO:1990742) |
0.2 | 1.8 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.2 | 3.0 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.2 | 0.8 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.2 | 1.7 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.2 | 0.8 | GO:0001652 | granular component(GO:0001652) |
0.2 | 1.7 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.2 | 0.2 | GO:0031012 | extracellular matrix(GO:0031012) |
0.2 | 2.9 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.2 | 0.7 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.2 | 13.7 | GO:0015030 | Cajal body(GO:0015030) |
0.2 | 0.7 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.2 | 2.0 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.2 | 1.8 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.2 | 4.5 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.2 | 3.8 | GO:0031528 | microvillus membrane(GO:0031528) |
0.2 | 10.2 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.2 | 0.5 | GO:1990666 | PCSK9-LDLR complex(GO:1990666) |
0.2 | 15.3 | GO:0034707 | chloride channel complex(GO:0034707) |
0.2 | 0.8 | GO:0032449 | CBM complex(GO:0032449) |
0.2 | 3.2 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.2 | 0.6 | GO:0031417 | NatC complex(GO:0031417) |
0.2 | 1.4 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.2 | 0.5 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.2 | 0.8 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
0.2 | 1.1 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.2 | 1.4 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.1 | 0.7 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
0.1 | 1.0 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.1 | 8.2 | GO:0034358 | plasma lipoprotein particle(GO:0034358) lipoprotein particle(GO:1990777) |
0.1 | 0.4 | GO:0098855 | HCN channel complex(GO:0098855) |
0.1 | 1.4 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.1 | 0.3 | GO:0035061 | interchromatin granule(GO:0035061) |
0.1 | 12.2 | GO:0005604 | basement membrane(GO:0005604) |
0.1 | 2.9 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.1 | 0.9 | GO:0098575 | lumenal side of lysosomal membrane(GO:0098575) |
0.1 | 1.3 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 5.8 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 2.5 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.1 | 1.6 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 1.1 | GO:0008091 | spectrin(GO:0008091) |
0.1 | 2.2 | GO:0098576 | lumenal side of membrane(GO:0098576) |
0.1 | 5.1 | GO:0005903 | brush border(GO:0005903) |
0.1 | 0.5 | GO:0045281 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.1 | 1.2 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 7.9 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 16.5 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.1 | 5.4 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 7.6 | GO:0035580 | specific granule lumen(GO:0035580) |
0.1 | 0.3 | GO:0000776 | kinetochore(GO:0000776) |
0.1 | 0.9 | GO:0097470 | ribbon synapse(GO:0097470) |
0.1 | 6.7 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 0.3 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
0.1 | 0.2 | GO:0032021 | NELF complex(GO:0032021) |
0.1 | 1.2 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 101.0 | GO:0016604 | nuclear body(GO:0016604) |
0.1 | 28.6 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 1.7 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.1 | 12.7 | GO:0005911 | cell-cell junction(GO:0005911) |
0.1 | 2.1 | GO:0005901 | caveola(GO:0005901) |
0.1 | 1.2 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 1.3 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 0.9 | GO:0000923 | equatorial microtubule organizing center(GO:0000923) |
0.1 | 0.4 | GO:1990423 | RZZ complex(GO:1990423) |
0.1 | 1.9 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.1 | 0.3 | GO:0071746 | IgA immunoglobulin complex(GO:0071745) IgA immunoglobulin complex, circulating(GO:0071746) monomeric IgA immunoglobulin complex(GO:0071748) polymeric IgA immunoglobulin complex(GO:0071749) secretory IgA immunoglobulin complex(GO:0071751) |
0.1 | 3.3 | GO:0005925 | focal adhesion(GO:0005925) |
0.1 | 0.4 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.1 | 0.6 | GO:1990037 | Lewy body core(GO:1990037) |
0.1 | 2.4 | GO:0044295 | axonal growth cone(GO:0044295) |
0.1 | 0.9 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.1 | 0.5 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
0.1 | 0.8 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.1 | 9.8 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.1 | 0.4 | GO:0038038 | G-protein coupled receptor homodimeric complex(GO:0038038) |
0.1 | 7.0 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 0.3 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 1.2 | GO:0051233 | spindle midzone(GO:0051233) |
0.1 | 0.3 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.1 | 0.3 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 7.3 | GO:0030175 | filopodium(GO:0030175) |
0.1 | 0.4 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.1 | 0.7 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 0.5 | GO:0061617 | MICOS complex(GO:0061617) |
0.1 | 2.7 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 0.9 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.1 | 0.2 | GO:0016938 | kinesin I complex(GO:0016938) |
0.1 | 0.4 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 1.8 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.1 | 1.0 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.1 | 1.5 | GO:0043235 | receptor complex(GO:0043235) |
0.1 | 0.2 | GO:0097443 | sorting endosome(GO:0097443) |
0.1 | 0.3 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.1 | 0.7 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
0.1 | 0.5 | GO:0071004 | U6 snRNP(GO:0005688) U2-type prespliceosome(GO:0071004) |
0.1 | 1.4 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 0.2 | GO:0055087 | Ski complex(GO:0055087) |
0.1 | 11.0 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 0.2 | GO:0098827 | endoplasmic reticulum tubular network(GO:0071782) endoplasmic reticulum subcompartment(GO:0098827) |
0.1 | 1.7 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 2.8 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 0.1 | GO:0043227 | membrane-bounded organelle(GO:0043227) |
0.1 | 2.0 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.1 | 0.6 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.1 | 0.9 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.2 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.1 | 0.6 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 1.2 | GO:0030686 | 90S preribosome(GO:0030686) |
0.1 | 5.0 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 0.3 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.1 | 0.5 | GO:0043034 | costamere(GO:0043034) |
0.1 | 0.3 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.1 | 291.1 | GO:0016021 | integral component of membrane(GO:0016021) |
0.1 | 1.3 | GO:0002102 | podosome(GO:0002102) |
0.1 | 0.8 | GO:0000800 | lateral element(GO:0000800) |
0.1 | 0.5 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.0 | 0.4 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.0 | 0.2 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.0 | 0.6 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.0 | 0.2 | GO:0099503 | secretory vesicle(GO:0099503) |
0.0 | 0.2 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.0 | 5.6 | GO:1904813 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
0.0 | 3.5 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 3.0 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 0.3 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.0 | 0.4 | GO:0000242 | pericentriolar material(GO:0000242) |
0.0 | 0.2 | GO:0005602 | complement component C1 complex(GO:0005602) |
0.0 | 0.8 | GO:0032982 | myosin filament(GO:0032982) |
0.0 | 2.1 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 1.0 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 0.7 | GO:0044215 | host(GO:0018995) host cell(GO:0043657) other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.0 | 4.8 | GO:0001650 | fibrillar center(GO:0001650) |
0.0 | 1.3 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.0 | 0.5 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.0 | 0.2 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.0 | 0.2 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
0.0 | 0.5 | GO:0043234 | protein complex(GO:0043234) |
0.0 | 0.1 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.0 | 0.4 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.0 | 0.2 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.0 | 0.4 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.4 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.0 | 0.1 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 0.1 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 0.1 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 0.2 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 0.2 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.0 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 0.2 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.0 | 1.3 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.0 | 0.0 | GO:0042588 | zymogen granule(GO:0042588) |
0.0 | 0.1 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 1.3 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.0 | 0.7 | GO:0000786 | nucleosome(GO:0000786) |
0.0 | 1.1 | GO:0031225 | anchored component of membrane(GO:0031225) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.1 | 55.0 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
4.9 | 14.8 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
3.4 | 16.9 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
3.1 | 40.2 | GO:0038132 | neuregulin binding(GO:0038132) |
3.0 | 9.1 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
3.0 | 33.5 | GO:0050544 | arachidonic acid binding(GO:0050544) |
2.1 | 20.6 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
2.0 | 7.9 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) phosphatidate cytidylyltransferase activity(GO:0004605) |
2.0 | 7.8 | GO:0030305 | beta-glucuronidase activity(GO:0004566) heparanase activity(GO:0030305) |
1.9 | 17.3 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
1.9 | 9.3 | GO:0050473 | arachidonate 15-lipoxygenase activity(GO:0050473) |
1.9 | 5.6 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
1.8 | 16.2 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
1.7 | 8.6 | GO:0005499 | vitamin D binding(GO:0005499) |
1.7 | 6.9 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
1.7 | 6.9 | GO:0002060 | purine nucleobase binding(GO:0002060) |
1.7 | 20.2 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
1.6 | 4.8 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
1.6 | 12.7 | GO:0070097 | delta-catenin binding(GO:0070097) |
1.5 | 13.8 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
1.4 | 7.2 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
1.4 | 4.3 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
1.3 | 11.8 | GO:0045294 | alpha-catenin binding(GO:0045294) |
1.3 | 9.0 | GO:1990254 | keratin filament binding(GO:1990254) |
1.3 | 8.9 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
1.2 | 8.7 | GO:0050682 | AF-2 domain binding(GO:0050682) |
1.2 | 3.7 | GO:0098782 | mechanically-gated potassium channel activity(GO:0098782) |
1.2 | 3.5 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
1.2 | 26.9 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
1.2 | 17.3 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
1.1 | 13.6 | GO:0042608 | T cell receptor binding(GO:0042608) |
1.1 | 10.9 | GO:0071253 | connexin binding(GO:0071253) |
1.1 | 17.4 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
1.1 | 1.1 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
1.1 | 7.4 | GO:0016416 | O-palmitoyltransferase activity(GO:0016416) |
1.0 | 5.2 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
1.0 | 1.0 | GO:0048406 | nerve growth factor binding(GO:0048406) |
1.0 | 15.2 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
1.0 | 15.9 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
1.0 | 2.0 | GO:0010465 | nerve growth factor receptor activity(GO:0010465) |
0.9 | 10.4 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.9 | 1.9 | GO:0061135 | endopeptidase regulator activity(GO:0061135) |
0.9 | 12.9 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.9 | 3.6 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.9 | 3.6 | GO:0097363 | protein O-GlcNAc transferase activity(GO:0097363) |
0.9 | 3.5 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.9 | 2.6 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.8 | 4.2 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
0.8 | 32.9 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.8 | 3.3 | GO:0015389 | pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
0.8 | 2.4 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.8 | 6.3 | GO:0004064 | arylesterase activity(GO:0004064) |
0.8 | 7.8 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.8 | 7.8 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.8 | 10.1 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.7 | 6.7 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.7 | 20.8 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.7 | 5.9 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.7 | 12.5 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.7 | 6.6 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.7 | 4.3 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.7 | 41.5 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.7 | 1.4 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.7 | 6.4 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.7 | 2.1 | GO:0005171 | hepatocyte growth factor receptor binding(GO:0005171) |
0.7 | 3.5 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.7 | 17.9 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.7 | 5.3 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.7 | 31.9 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.7 | 2.0 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
0.7 | 4.6 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.6 | 1.3 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.6 | 38.8 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.6 | 8.5 | GO:0031014 | troponin T binding(GO:0031014) |
0.6 | 4.3 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.6 | 38.8 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.6 | 0.6 | GO:0050436 | microfibril binding(GO:0050436) |
0.6 | 2.9 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
0.6 | 1.7 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
0.6 | 3.4 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
0.5 | 2.7 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.5 | 0.5 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.5 | 21.9 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.5 | 71.8 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.5 | 1.6 | GO:0003870 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
0.5 | 11.7 | GO:0038191 | neuropilin binding(GO:0038191) |
0.5 | 7.9 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.5 | 2.1 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
0.5 | 12.0 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.5 | 9.9 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.5 | 11.9 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.5 | 13.9 | GO:0005112 | Notch binding(GO:0005112) |
0.5 | 4.6 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.5 | 1.5 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
0.5 | 11.8 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.5 | 3.0 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.5 | 2.0 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
0.5 | 1.9 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.5 | 34.3 | GO:0019894 | kinesin binding(GO:0019894) |
0.5 | 2.4 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.5 | 0.9 | GO:0005350 | pyrimidine nucleobase transmembrane transporter activity(GO:0005350) |
0.5 | 5.1 | GO:0000982 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) |
0.5 | 1.4 | GO:0047025 | 3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity(GO:0047025) |
0.5 | 1.4 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.5 | 2.7 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.4 | 4.9 | GO:0097016 | L27 domain binding(GO:0097016) |
0.4 | 1.8 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.4 | 9.6 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.4 | 7.8 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.4 | 3.3 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.4 | 1.7 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.4 | 1.2 | GO:0004819 | glutamine-tRNA ligase activity(GO:0004819) |
0.4 | 1.6 | GO:0005457 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
0.4 | 3.2 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.4 | 4.4 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.4 | 1.6 | GO:0004102 | choline O-acetyltransferase activity(GO:0004102) |
0.4 | 1.2 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.4 | 16.3 | GO:0005109 | frizzled binding(GO:0005109) |
0.4 | 0.8 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.4 | 10.9 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.4 | 1.9 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.4 | 1.9 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.4 | 0.7 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.4 | 2.6 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.4 | 14.2 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.4 | 1.1 | GO:0003883 | CTP synthase activity(GO:0003883) |
0.4 | 25.1 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.4 | 1.5 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
0.4 | 2.2 | GO:0045029 | UDP-activated nucleotide receptor activity(GO:0045029) |
0.4 | 6.8 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.4 | 14.0 | GO:0043236 | laminin binding(GO:0043236) |
0.4 | 1.8 | GO:0035173 | histone kinase activity(GO:0035173) histone threonine kinase activity(GO:0035184) |
0.4 | 1.8 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.4 | 1.4 | GO:0003974 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
0.4 | 17.3 | GO:0003785 | actin monomer binding(GO:0003785) |
0.4 | 2.5 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.3 | 2.1 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.3 | 10.0 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.3 | 4.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.3 | 1.3 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
0.3 | 9.6 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.3 | 5.9 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.3 | 1.6 | GO:0045545 | syndecan binding(GO:0045545) |
0.3 | 1.6 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.3 | 3.5 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.3 | 1.0 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
0.3 | 1.9 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.3 | 2.5 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.3 | 3.7 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.3 | 4.6 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.3 | 2.7 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.3 | 1.5 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.3 | 34.3 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.3 | 1.5 | GO:0050692 | DBD domain binding(GO:0050692) |
0.3 | 0.9 | GO:0047325 | inositol tetrakisphosphate 1-kinase activity(GO:0047325) inositol-1,3,4-trisphosphate 6-kinase activity(GO:0052725) inositol-1,3,4-trisphosphate 5-kinase activity(GO:0052726) inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity(GO:0052825) inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity(GO:0052830) inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity(GO:0052831) inositol-3,4,6-trisphosphate 1-kinase activity(GO:0052835) |
0.3 | 1.8 | GO:0034046 | poly(G) binding(GO:0034046) |
0.3 | 1.5 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.3 | 3.0 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.3 | 0.9 | GO:0047726 | iron-cytochrome-c reductase activity(GO:0047726) |
0.3 | 2.0 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.3 | 1.7 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.3 | 95.3 | GO:0003729 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
0.3 | 2.6 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.3 | 1.1 | GO:1903136 | cuprous ion binding(GO:1903136) |
0.3 | 2.0 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
0.3 | 2.8 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.3 | 4.1 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.3 | 1.6 | GO:0016316 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
0.3 | 3.3 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.3 | 1.6 | GO:0008481 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
0.3 | 0.8 | GO:0052596 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
0.3 | 0.8 | GO:0000035 | acyl binding(GO:0000035) |
0.3 | 1.3 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
0.3 | 1.1 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
0.3 | 8.0 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.3 | 1.3 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.3 | 2.1 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.3 | 3.2 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.3 | 0.8 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
0.3 | 1.0 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.3 | 0.8 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.3 | 1.3 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.3 | 0.8 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
0.2 | 0.2 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.2 | 1.0 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
0.2 | 0.7 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.2 | 1.4 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.2 | 4.3 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.2 | 0.7 | GO:0098808 | mRNA cap binding(GO:0098808) |
0.2 | 3.1 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.2 | 4.7 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.2 | 15.9 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.2 | 0.9 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
0.2 | 7.1 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.2 | 3.2 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.2 | 1.4 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
0.2 | 1.6 | GO:0048156 | tau protein binding(GO:0048156) |
0.2 | 6.1 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.2 | 2.9 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.2 | 0.9 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.2 | 0.7 | GO:0003968 | RNA-directed RNA polymerase activity(GO:0003968) |
0.2 | 0.9 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
0.2 | 1.3 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.2 | 3.7 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.2 | 6.1 | GO:0030553 | cGMP binding(GO:0030553) |
0.2 | 2.8 | GO:0000182 | rDNA binding(GO:0000182) |
0.2 | 1.1 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.2 | 2.1 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.2 | 3.8 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.2 | 0.8 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.2 | 8.8 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.2 | 0.6 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
0.2 | 2.3 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.2 | 3.7 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.2 | 2.8 | GO:0008199 | ferric iron binding(GO:0008199) |
0.2 | 2.0 | GO:0016725 | oxidoreductase activity, acting on CH or CH2 groups(GO:0016725) |
0.2 | 1.0 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.2 | 0.6 | GO:0004347 | glucose-6-phosphate isomerase activity(GO:0004347) |
0.2 | 5.5 | GO:0031489 | myosin V binding(GO:0031489) |
0.2 | 58.7 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.2 | 3.1 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.2 | 31.3 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.2 | 2.3 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.2 | 1.7 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.2 | 0.4 | GO:1990763 | arrestin family protein binding(GO:1990763) |
0.2 | 1.0 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
0.2 | 0.8 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
0.2 | 1.3 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.2 | 0.7 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.2 | 0.7 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.2 | 1.6 | GO:0051766 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
0.2 | 18.7 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.2 | 3.8 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
0.2 | 0.7 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.2 | 2.0 | GO:0031419 | cobalamin binding(GO:0031419) |
0.2 | 0.5 | GO:0045155 | electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity(GO:0045155) |
0.2 | 1.0 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.2 | 0.5 | GO:0016015 | morphogen activity(GO:0016015) |
0.2 | 1.7 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.2 | 1.5 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.2 | 7.5 | GO:0030507 | spectrin binding(GO:0030507) |
0.2 | 0.9 | GO:0004925 | prolactin receptor activity(GO:0004925) |
0.2 | 3.9 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.2 | 0.3 | GO:0032183 | SUMO binding(GO:0032183) |
0.2 | 31.3 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
0.2 | 1.4 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.2 | 0.9 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.2 | 1.9 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.2 | 0.8 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.2 | 0.5 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.1 | 0.7 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.1 | 4.2 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 0.9 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.1 | 0.6 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 1.6 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.1 | 0.4 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.1 | 1.3 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 0.9 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 1.4 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
0.1 | 0.7 | GO:0060175 | brain-derived neurotrophic factor-activated receptor activity(GO:0060175) |
0.1 | 0.7 | GO:0004882 | androgen receptor activity(GO:0004882) |
0.1 | 0.4 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.1 | 0.8 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 2.3 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.1 | 0.4 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.1 | 0.7 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.1 | 0.9 | GO:0030267 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.1 | 13.4 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.1 | 2.5 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.1 | 0.5 | GO:0005497 | androgen binding(GO:0005497) |
0.1 | 2.2 | GO:0005346 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) |
0.1 | 12.4 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.1 | 5.8 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 1.4 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.1 | 0.6 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.1 | 0.7 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.1 | 1.6 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 2.6 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 0.3 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.1 | 0.8 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 1.7 | GO:0005542 | folic acid binding(GO:0005542) |
0.1 | 1.9 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 0.7 | GO:0023025 | MHC class Ib protein complex binding(GO:0023025) MHC class Ib protein binding, via antigen binding groove(GO:0023030) |
0.1 | 0.4 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 0.8 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
0.1 | 0.6 | GO:0050610 | oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor(GO:0016672) glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
0.1 | 0.2 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
0.1 | 0.5 | GO:0052740 | 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
0.1 | 0.3 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.1 | 1.1 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.8 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
0.1 | 1.6 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.1 | 0.5 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 0.3 | GO:0032551 | pyrimidine nucleoside binding(GO:0001884) UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
0.1 | 1.0 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
0.1 | 1.1 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.1 | 18.6 | GO:0005125 | cytokine activity(GO:0005125) |
0.1 | 0.7 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 0.8 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
0.1 | 1.3 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 0.4 | GO:0016499 | orexin receptor activity(GO:0016499) |
0.1 | 5.5 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 1.6 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 2.1 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 0.9 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 1.2 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.1 | 0.4 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.1 | 0.6 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 0.4 | GO:0008941 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) fatty acid peroxidase activity(GO:0047888) |
0.1 | 0.1 | GO:0005507 | copper ion binding(GO:0005507) |
0.1 | 0.6 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 6.4 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 0.1 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.1 | 0.4 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.1 | 0.5 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.1 | 2.1 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.1 | 0.4 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
0.1 | 1.0 | GO:0001851 | complement component C3b binding(GO:0001851) |
0.1 | 0.3 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
0.1 | 0.6 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.1 | 0.8 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 1.8 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.1 | 3.0 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 2.3 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 1.2 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.1 | 0.5 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.1 | 0.6 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.1 | 2.2 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 0.2 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.1 | 0.3 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
0.1 | 0.5 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 0.3 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.1 | 0.4 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 0.2 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
0.1 | 0.3 | GO:0004530 | deoxyribonuclease I activity(GO:0004530) |
0.1 | 6.7 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.1 | 0.3 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 0.7 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.1 | 1.1 | GO:0005549 | odorant binding(GO:0005549) |
0.1 | 0.3 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.1 | 0.4 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
0.1 | 1.1 | GO:0070330 | aromatase activity(GO:0070330) |
0.1 | 3.1 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.1 | 4.6 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.1 | 0.3 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.1 | 0.6 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.1 | 1.2 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.1 | 0.4 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 4.5 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 0.5 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.1 | 0.2 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.1 | 0.3 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.1 | 0.4 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
0.1 | 3.0 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.1 | 0.8 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 4.8 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 0.4 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 0.2 | GO:0005504 | fatty acid binding(GO:0005504) |
0.1 | 0.5 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) |
0.1 | 0.4 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.1 | 0.3 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.1 | 0.5 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 1.8 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.1 | 3.4 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.1 | 0.5 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 0.5 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.1 | 1.9 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.1 | 0.1 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
0.1 | 1.2 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
0.1 | 0.4 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.1 | 0.6 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.1 | 0.4 | GO:0019826 | oxygen sensor activity(GO:0019826) |
0.1 | 5.3 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.1 | 0.6 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.0 | 1.3 | GO:0015295 | solute:proton symporter activity(GO:0015295) |
0.0 | 1.9 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.0 | 0.4 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.0 | 1.8 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.0 | 0.1 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.0 | 1.0 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.0 | 0.4 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.0 | 0.3 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.0 | 0.2 | GO:0030337 | DNA polymerase processivity factor activity(GO:0030337) |
0.0 | 0.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.0 | 0.3 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.0 | 6.9 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 0.7 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.0 | 0.6 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 1.5 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 0.7 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.1 | GO:0071566 | UFM1 activating enzyme activity(GO:0071566) |
0.0 | 1.4 | GO:0003823 | antigen binding(GO:0003823) |
0.0 | 0.3 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.2 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.0 | 0.2 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.0 | 0.1 | GO:0030366 | molybdopterin synthase activity(GO:0030366) |
0.0 | 0.3 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.0 | 0.4 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.0 | 0.4 | GO:0031996 | thioesterase binding(GO:0031996) |
0.0 | 6.0 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 0.3 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.0 | 0.3 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.0 | 0.3 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.1 | GO:0070259 | tyrosyl-DNA phosphodiesterase activity(GO:0070259) |
0.0 | 12.1 | GO:0045296 | cadherin binding(GO:0045296) |
0.0 | 0.5 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.2 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.0 | 0.4 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.0 | 0.1 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
0.0 | 0.1 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.0 | 1.1 | GO:0000049 | tRNA binding(GO:0000049) |
0.0 | 0.3 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.0 | 0.5 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.1 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.0 | 0.4 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.0 | 0.5 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.0 | 1.0 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 0.1 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.0 | 0.7 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.0 | 0.3 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.0 | 0.8 | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
0.0 | 0.1 | GO:0070984 | SET domain binding(GO:0070984) |
0.0 | 0.5 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.0 | 0.2 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.0 | 0.1 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.0 | 0.7 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.3 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.0 | 0.2 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.0 | 0.2 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.0 | 0.6 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.0 | 0.2 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.0 | 0.2 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.0 | 2.7 | GO:0008201 | heparin binding(GO:0008201) |
0.0 | 0.1 | GO:0004419 | hydroxymethylglutaryl-CoA lyase activity(GO:0004419) |
0.0 | 0.1 | GO:0016901 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.0 | 0.3 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.0 | 0.2 | GO:0015232 | heme transporter activity(GO:0015232) |
0.0 | 0.2 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.0 | 0.1 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.0 | 0.4 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.0 | 0.6 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 0.2 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 0.4 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
0.0 | 0.3 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.0 | 0.5 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.0 | 0.0 | GO:0015403 | thiamine uptake transmembrane transporter activity(GO:0015403) |
0.0 | 0.3 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.0 | 0.1 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.0 | 0.3 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.0 | 1.4 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.0 | 1.5 | GO:0005496 | steroid binding(GO:0005496) |
0.0 | 0.2 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.0 | 0.1 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
0.0 | 0.0 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
0.0 | 0.2 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 0.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.0 | 0.1 | GO:0003680 | AT DNA binding(GO:0003680) |
0.0 | 0.5 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 45.4 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
1.7 | 60.5 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
1.0 | 34.4 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.9 | 35.9 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.9 | 0.9 | ST STAT3 PATHWAY | STAT3 Pathway |
0.7 | 25.1 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.7 | 23.9 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.7 | 18.2 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.5 | 3.5 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.4 | 12.0 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.4 | 3.5 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.3 | 14.5 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.3 | 11.3 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.3 | 11.9 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.3 | 5.5 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.3 | 6.3 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.3 | 2.3 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.3 | 0.6 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.3 | 13.0 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.3 | 1.7 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.3 | 1.8 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.2 | 24.0 | PID LKB1 PATHWAY | LKB1 signaling events |
0.2 | 10.8 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.2 | 13.9 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.2 | 10.8 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.2 | 10.5 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.2 | 8.1 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.2 | 3.6 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.2 | 8.8 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.2 | 5.0 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.2 | 85.9 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.2 | 29.1 | PID P73PATHWAY | p73 transcription factor network |
0.2 | 8.3 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.2 | 8.0 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.2 | 11.6 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.2 | 0.4 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.2 | 7.8 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.2 | 1.4 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.2 | 3.4 | PID FGF PATHWAY | FGF signaling pathway |
0.2 | 1.4 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.1 | 6.5 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 8.9 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 2.9 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 3.7 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 11.0 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.1 | 1.2 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.1 | 2.0 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 0.4 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 1.1 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 2.3 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.1 | 1.1 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 5.4 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 1.3 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 2.4 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 3.7 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 1.4 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 6.3 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 2.3 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 1.2 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 1.2 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 4.0 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 1.0 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.5 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 4.3 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 1.1 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.8 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.4 | PID EPO PATHWAY | EPO signaling pathway |
0.0 | 0.5 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.3 | ST ADRENERGIC | Adrenergic Pathway |
0.0 | 0.3 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.4 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.4 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.3 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 0.6 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 0.4 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.4 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.1 | 59.0 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
2.3 | 97.3 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
2.0 | 63.5 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
1.5 | 19.5 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
1.3 | 22.2 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
1.3 | 31.7 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
1.2 | 26.2 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
1.0 | 1.0 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.9 | 19.9 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.8 | 18.1 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.7 | 14.7 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.7 | 19.9 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.7 | 18.3 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.7 | 26.4 | REACTOME KINESINS | Genes involved in Kinesins |
0.7 | 9.6 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.7 | 10.9 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.6 | 0.6 | REACTOME PHOSPHOLIPASE C MEDIATED CASCADE | Genes involved in Phospholipase C-mediated cascade |
0.6 | 16.6 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.6 | 53.2 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.6 | 29.3 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.6 | 10.0 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.5 | 8.9 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.5 | 8.5 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.5 | 16.3 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.5 | 2.4 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.4 | 10.3 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.4 | 15.4 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.4 | 8.9 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.4 | 15.9 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.4 | 5.6 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.4 | 4.7 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.4 | 10.2 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.3 | 8.4 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.3 | 7.7 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.3 | 5.1 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.3 | 9.5 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.3 | 20.1 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.3 | 4.9 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.3 | 6.6 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.3 | 5.6 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.3 | 7.2 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.2 | 4.7 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.2 | 4.7 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.2 | 6.8 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.2 | 9.1 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.2 | 3.0 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.2 | 2.8 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.2 | 1.7 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.2 | 3.5 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.2 | 7.7 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.2 | 6.0 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.2 | 14.3 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 8.5 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.1 | 8.2 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 7.0 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.1 | 6.8 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 1.7 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 11.9 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.1 | 1.3 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.1 | 1.8 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.1 | 4.7 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 1.9 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 2.7 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.1 | 1.2 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 0.7 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.1 | 1.9 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 2.6 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.1 | 2.8 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 0.7 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.1 | 5.5 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.1 | 2.3 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.1 | 1.3 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 2.0 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 2.4 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 2.2 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 1.9 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 0.9 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.1 | 1.7 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 1.6 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.1 | 2.2 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.1 | 2.3 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.1 | 1.7 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 2.5 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 1.1 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.1 | 4.1 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 2.7 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 2.1 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.1 | 4.3 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 0.8 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 1.9 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.1 | 0.4 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.1 | 2.8 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 0.6 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.1 | 1.6 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 4.2 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.1 | 0.6 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.1 | 0.9 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 0.4 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.0 | 0.8 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.0 | 1.0 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.6 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.0 | 0.7 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
0.0 | 2.7 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 1.6 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.0 | 0.5 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.0 | 0.3 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 3.0 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 4.7 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.4 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.0 | 1.2 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.5 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.0 | 2.3 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.3 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.0 | 2.4 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.7 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.0 | 0.2 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 0.5 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 0.5 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 0.4 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.0 | 1.1 | REACTOME SIGNALING BY ILS | Genes involved in Signaling by Interleukins |
0.0 | 1.0 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 0.4 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.0 | 0.1 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.0 | 0.1 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.0 | 2.1 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.0 | 0.3 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.0 | 0.2 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.0 | 0.1 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.9 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.0 | 0.1 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 1.3 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.0 | 0.1 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.0 | 0.6 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.0 | 0.2 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |